vancomycin has been researched along with Primary Peritonitis in 222 studies
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 49 (22.07) | 18.7374 |
1990's | 70 (31.53) | 18.2507 |
2000's | 44 (19.82) | 29.6817 |
2010's | 44 (19.82) | 24.3611 |
2020's | 15 (6.76) | 2.80 |
Authors | Studies |
---|---|
Bürli, RW; Chen, A; Duan, JX; Ge, Y; Gross, M; Hu, W; Iwamoto, M; Jiang, V; Johnson, KW; Jones, P; Kaizerman, JA; Moser, HE; Stanton, T; Touami, S; Truong, K | 1 |
Alder, JD; Li, T; Mortin, LI; Van Praagh, AD; Zhang, S; Zhang, XX | 1 |
Arias, CA; Murray, BE; Panesso, D; Rice, LB; Singh, KV | 1 |
Deng, Y; Duan, Y; Huang, Y; Kang, D; Li, Y; Liu, X; Qiu, L; Shen, B; Su, M; Wen, Z | 1 |
Adeniyi, ET; Chen, S; Drießen, D; Ioerger, TR; Kalscheuer, R; Kruppa, M; Müller, TJJ; Rehberg, N; Sommer, GA; Tasch, BOA; Wang, L; Wolf, K; Zhu, K | 1 |
Ataman, MR; Guzel, SS; Murt, A; Olcar, S; Ozkan Tekin, T; Salihoglu, A | 1 |
Chang, WM; Cheng, E; Shalansky, K; Singh, SR | 1 |
Geng, Y; Jin, L; Liang, C; Lu, W; Lv, J; Ma, Y; Wang, X; Xie, L | 1 |
Chen, X; Liu, L; Rao, Z; Tang, M; Yin, S; Zhang, K; Zhang, M | 1 |
Dohi, K; Hirabayashi, Y; Katayama, K; Murata, T; Oda, K; Saiki, R; Takahashi, D; Tanaka, F; Tsujimoto, K | 1 |
Biyani, M; Brown, P; Canney, M; Deacon, E; McCormick, B; Zimmerman, D | 1 |
Caniff, K; Dukarevich, Y; Elfessi, Z; Liu, E; Marquez, K; Shabbir, Z | 1 |
Bogoslowski, A; Deng, J; Deppermann, C; Hickey, MJ; Hossain, M; Jorch, SK; Kubes, P; Omri, A; Peiseler, M; Surewaard, BG; van der Wal, F | 1 |
Lantos, PM; Meservey, A; Sullivan, A; Wu, C | 1 |
Al Qarni, A; Arapis, K; Augustin, P; Grall, N; Montravers, P; Parenti Ribeiro, L; Tanaka, S; Tran-Dinh, A | 1 |
Kraft, WK; Lam, E; Lien, YTK; Piraino, B; Schmidt, S; Vozmediano, V; Zhang, J | 1 |
Alejandro, L; Benador, N; Capparelli, EV; Hennessy, K; Murray, W; Romanowski, G | 1 |
Abe, T; Hirata, K; Morikawa, K; Nozaki, M; Wada, K; Yanagihara, I | 1 |
Barajas-Colon, E; Warady, BA | 1 |
Kimura, T; Tanemoto, M; Yokoyama, T | 1 |
Hsu, CY; Lee, DJ; Lin, SH | 1 |
Cao, Y; Fan, G; Lou, Y; Wang, J; Wang, S; Wu, S; Zhao, X; Zhou, T | 1 |
Campbell, D; Craig, JC; Johnson, DW; Mudge, DW; Strippoli, GF; Tong, A | 1 |
Chow, KM; Kwan, BC; Kwong, VW; Law, MC; Leung, CB; Li, PK; Ng, JK; Szeto, CC | 1 |
Ariyamuthu, VK; Choti, M; Khan, KN; Saxena, R | 1 |
Bae, EH; Choi, HS; Kim, SW; Ma, SK; Shin, JH; Song, SH | 1 |
Hao, Y; Mao, R; Teng, D; Wang, J; Wang, X; Wang, Z; Yang, N | 1 |
Company-Albir, MJ; García-Robles, A; Marqués-Miñana, MR; Poveda, JL; Torres-Martinez, E; Vento-Torres, M | 1 |
Gong, N; Jiang, J; Yang, L; Zhou, H | 1 |
Cavanagh, JP; Christophersen, L; Flaegstad, T; Fredheim, EA; Granslo, HN; Jensen, PØ; Klingenberg, C; Moser, C; Thomsen, K; Van Gennip, M | 1 |
Garrett, TR; Gosmanova, EO; Wall, BM | 1 |
Chow, KM; Kwan, BC; Lee, KP; Leung, CB; Li, PK; Ma, TK; Szeto, CC | 1 |
Barretti, P; Camargo, CH; Caramori, JC; Cunha, Mde L; Mondelli, AL; Montelli, AC | 1 |
Cunningham, ML; Fenical, W; Haste, NM; Hensler, ME; Jang, KH; Kwan, BP; Lin, L; Nizet, V; Shaw, KJ; Soubih, E; Thienphrapa, W; Tran, DN; Vuong, L | 1 |
Covens, L; Echahidi, F; François, K; Piérard, D; Pipeleers, L; Wybo, I; Yusuf, E | 1 |
Lebeaux, D; Touam, M | 1 |
Dominguez, MD; Mendiola, NR; Quereda, C; Rivera, M; Roso, GR | 1 |
Escosa-García, L; García-Gil, V; Gómez-Gil, MR; Hierro-Llanillo, L | 1 |
Díaz-Domínguez, M; Quereda-Rodríguez-Navarro, C; Rivera-Gorrin, M; Rodríguez-Mendiola, N; Ruiz-Roso, G; Teruel-Briones, JL | 1 |
Azzam, O; Crowe, A; Pawar, B; Sajiv, C | 1 |
Branco, P; Gaspar, A; Martins, AR | 1 |
Barua, A; Deweese, R; Slavens, J; Sutton, J | 1 |
Dotis, J; Gkogka, C; Myserlis, P; Papachristou, F; Pavlaki, A; Printza, N; Stabouli, S | 1 |
Dong, J; Johnson, DW; Qu, Z; Tian, X; Wang, H; Xu, R; Yang, Z | 1 |
Hattori, N; Hirano, K; Iwanaga, N; Izumikawa, K; Kajihara, T; Kohno, N; Kohno, S; Miyazaki, T; Miyazaki, Y; Mukae, H; Nakamura, S; Oshima, K; Yanagihara, K | 1 |
Chung, GE; Kim, BH; Kim, EC; Kim, W; Kim, YJ; Lee, HS; Lee, JH; Myung, SJ; Yoon, JH | 1 |
Bert, F; Bourdon, N; Le Grand, J; Leflon-Guibout, V; Nicolas-Chanoine, MH | 1 |
Cleveland, KO; Lacasse, A | 1 |
Fujinaga, S; Hirano, D; Kaneko, K; Nishizaki, N; Ohtomo, Y; Ohtsuka, Y; Shimizu, T; Someya, T | 1 |
Abu-Alfa, AK; Brewster, UC; Hall, I; Huen, SC; Mahnensmith, RL; Topal, J | 1 |
Chow, KM; Chung, KY; Kwan, BC; Law, MC; Leung, CB; Li, PK; Pang, WF; Szeto, CC | 1 |
Bannister, KM; Brown, FG; Hawley, CM; Johnson, DW; McDonald, SP; O'Shea, S; Rosman, JB; Wiggins, KJ | 1 |
Agudelo, M; Cataño, JC; Rodriguez, CA; Vesga, O; Zuluaga, AF | 1 |
Batard, E; Caillon, J; Caroff, N; Hello, M; Jacqueline, C; Potel, G | 1 |
Silverstein, DM; Wilcox, JE | 1 |
Kocyigit, I; Oymak, O; Sipahioglu, MH; Somdas, MA; Tokgoz, B; Ucar, C; Unal, A; Utas, C | 1 |
Ariza, J; Cabellos, C; Domínguez, MA; Fernández, R; Gudiol, F; Pachón-Ibáñez, ME; Ribes, S; Tubau, F | 2 |
Klemt-Kropp, M; Poortvliet, W; Raasveld, MH; Selten, HP | 1 |
Higashi, M; Iwasaka, T; Kakimoto, S; Kido, E; Morimoto, S; Morita, T; Someya, K; Sumitani, N; Suzuki, K; Takagishi, H; Yasui, A | 1 |
Agkus, C; Kocyigit, I; Oymak, O; Unal, A; Utas, C | 1 |
Bargman, JM; Heywood, A | 1 |
Almiñana, MA; Casabó Alós, VG; Montañés Pauls, B | 1 |
Kocyigit, I; Oymak, O; Sipahioglu, M; Somdas, M; Tokgoz, B; Ucar, C; Unal, A; Utas, C; Vural, A | 1 |
Azak, A; Duranay, M; Huddam, B; Işcan, G; Kocak, G | 1 |
Cabrita, A; Carvalho, MJ; Freitas, C; Rodrigues, A | 1 |
Barretti, P; Caramori, JC; Cunha, Mde L; Luengo, J; Montelli, AC; Oliveira, LG | 1 |
Barretti, P; Camargo, CH; Caramori, JC; da Cunha, Mde L; Mondelli, AL; Montelli, AC; Moraes, TM | 1 |
Bäckhed, F; Chiang, N; Fredman, G; Oh, SF; Schmidt, BA; Serhan, CN; Vickery, T | 1 |
Cabrita, A; Carvalho, MJ; Mendonça, D; Rocha, A; Rodrigues, A; Teixeira, L | 1 |
Gillespie, RS; McDonald, RA; Symons, JM | 1 |
Murray, BE; Nannini, EC; Pai, SR; Singh, KV | 1 |
Bernstein, JM; Bogard, L; Clarridge, JE; Neef, PA; Polenakovik, H; Saklayen, M | 1 |
Batiste, B; Bürli, R; Duan, JX; Garcia, M; Gross, M; Hoch, U; Jiang, V; Johnson, KW; Jones, P; Kaizerman, J; Moser, H; Tanaka, R | 1 |
Hasegawa, T; Ideura, T; Ito, Y; Iwasaki, S; Suzuki, R; Yamamoto, T; Yoshimura, A | 1 |
Hermsen, ED; Hotchkiss, JR; Hovde, LB; Rotschafer, JC | 1 |
Freeman, AF; Lane, JC; Shulman, ST; Zheng, XT | 1 |
Appelbaum, PC; Bozdogan, B; Bürli, RW; Chen, H; Difuntorum, S; Gross, MI; Hu, W; Iwamoto, M; Johnson, KW; Jones, P; Kaizerman, JA; Lofland, D; Moser, HE | 1 |
Palasuntheram, C; Perera, S | 1 |
Jeyaratnam, D; Keenan, N; Sheerin, NS | 1 |
Gock, H; Langham, R; Mullins, K; Murphy, B; Snider, J; Toussaint, N | 1 |
Leppänen, H; Metsärinne, KP; Nikoskelainen, J; Tertti, R | 1 |
Anijeet, H; Corkill, JE; Parry, CM; Saxena, R; Taegtmeyer, M | 1 |
Arima, H; Hoshitani, K; Ikeda, N; Kobayashi, K; Nakamoto, H; Okada, H; Okada, S; Shoda, J; Sugahara, S; Suzuki, H; Takane, Y; Uchida, K | 1 |
Chatterjee, I; Iredell, JR; Lipman, J; Woods, M | 1 |
Ashman, N; Blunden, M; Fan, SL; Zeitlin, D | 1 |
Bashashati, M; Keramati, MR; Yegane, RA | 1 |
Gejyo, F; Iino, N; Maruyama, H; Nakamura, G; Ota, K; Shimotori, M; Tanabe, Y; Tsukada, H | 1 |
Cengiz, CK | 1 |
Chow, KM; Chung, KY; Kwan, BC; Lau, MF; Law, MC; Leung, CB; Li, PK; Szeto, CC | 1 |
Adu, D; Gruer, LD; Kiddy, K; Michael, J | 1 |
Ayliffe, GA; Bartlett, R; Gruer, LD | 1 |
Johnson, CA; Rogge, M; Zimmerman, SW | 1 |
Ferraris, R; Nahum, M; Pesce, L; Poloniato, G | 1 |
Aronoff, GR; Brier, ME; Bunke, CM; Luft, FC; Sloan, RS | 1 |
Lauwers, S; Mouton, MC; Pierard, D; Sennesael, J; Verbeelen, D | 1 |
Buggy, BP; Schaberg, DR; Swartz, RD | 1 |
Fenton, P | 1 |
Duffy, WB; Krothapalli, R; Lacke, C; Patel, H; Payne, W; Perez, V; Senekjian, HO | 1 |
Arroyo, JC; Magera, BE; Postic, B; Rosansky, SJ | 1 |
Ayus, JC; Krothapalli, RK; Senekjian, HO | 1 |
Bohnen, JM; Burnett, RJ; Dellinger, EP; Haverstock, DC; Reinhart, HH; Rotstein, OD; Solomkin, JS; Vogel, SB | 1 |
Anwar, N; Gokal, R; Merchant, M; Tooth, A; Uttley, L; Were, T | 1 |
Bistrup, C; Pedersen, RS; Siboni, AH | 1 |
Braden, GL; Germain, MJ; Lipkowitz, GS; Madden, RL; Mulhern, JG; O'Shea, MH | 1 |
George, RC; Johnson, AP; Sanyal, D; Williams, AJ | 1 |
Banerji, C; Morgan, JR; Wheeler, DC | 1 |
Lee, EJ; Lye, WC; van der Straaten, J | 1 |
Keller, E | 1 |
Gibson, SP; Hawkins, JB; Manji, MR; Nwosu, AC; Nye, KJ; Robinson, BH | 1 |
Davenport, A | 1 |
Klaus, G; Mehls, O; Müller-Wiefel, D; Schaefer, F | 1 |
Hagelskjaer, LH; Møller, JK | 2 |
Baranowicz, I; Janicka, L; Kozioł, M; Ksiazek, A | 1 |
Ishizaki, M; Miyashita, E; Oikawa, K | 1 |
Fikrig, M; Finkelstein, FO; Golden, M; Gorban-Brennan, N; Kliger, AS; Troidle, L | 1 |
Radovanović, Lj | 1 |
Espinoza, R; Fung, J; Kusne, S; Pasculle, AW; Rakela, J; Wada, S | 1 |
Espersen, F; Frimodt-Møller, N; Fuursted, K; Knudsen, JD | 1 |
Piraino, B | 1 |
Bren, AF; Gucek, A; Hergouth, V; Lindic, J | 1 |
Gigi, J; Goffin, E; Pouthier, D; van Ypersele de Strihou, C; Vandercam, B | 1 |
Hargrave, J; Roberts, RB; Serur, D; Sieradzki, K; Tomasz, A | 2 |
Aziz, NS; Gendeh, BS; Gibb, AG; Kong, N; Zahir, ZM | 1 |
Klein, G; Louwers, J; Schindler, R; Zill, E | 1 |
Conrads, G; Ehrhard, I; Haase, G; Schmitt, H; Schnitzler, N | 1 |
Amimoto, D; Ito, T; Katsutani, M; Kushihata, S; Masaki, T; Nishida, Y; Oda, H; Taniguchi, Y; Yamakido, M; Yorioka, N | 1 |
Klaus, G; Mehls, O; Müller-Wiefel, DE; Schaefer, F | 1 |
Band, JD; Cruz, C; Jarvis, WR; Lancaster, MV; Pearson, ML; Robinson-Dunn, B; Smith, TL; Tenover, FC; White, E; Wilcox, KR; Zervos, MJ | 1 |
Eliott, TS; Lipkin, GW; Majumdar, A; Wheeler, DC | 1 |
Müller-Wiefel, DE | 1 |
Espersen, F; Frimodt-Moller, N; Fuursted, K; Knudsen, JD; Raber, S | 1 |
Collins, J; Disney, A; Harris, DC; Ibels, LS; Murphy, BF; Rigby, R; Saltissi, D; Suranyi, M | 1 |
Gadallah, MF; Mignone, J; Mitchell, L; Patel, D; Ramdeen, G; Tatro, S; Torres, C | 1 |
Gadallah, MF; Mignone, J; Mitchell, L; Patel, D; Ramdeen, G; Tatro, S | 1 |
Gokal, R | 1 |
Azadian, B; Brown, EA; Clemenger, M; Goldberg, L | 1 |
Duch, JM; Yee, J | 1 |
Chow, KM; Leung, CB; Li, PK; Lui, SF; Szeto, CC; Wang, AY; Wong, TY; Wu, AK | 1 |
Dunne , WM; Nafziger, DA; Pervez, H; Qureshi, H | 1 |
Chak, WL; Chan, YH; Chau, KF; Cheung, CY; Choi, KS; Leung, J; Leung, SH; Li, CS; Tsang, DN; Wong, KM | 1 |
Ahmad, R; Binukrishnan, S; Howse, M; Neal, T | 1 |
Aber, RC; Crook, T; Riley, T; Templin, KS; Whitener, C | 1 |
Barki, Y; Cohen, Z; Kleiner, O; Mares, AJ | 1 |
Akil, IO; Mir, S | 1 |
Ayus, JC; Becker, CE; Benowitz, NL; Eneas, JF; Hadley, KL; Humphreys, MH; Schoenfeld, PY; Tong, TG | 1 |
Hansen, HE; Nielsen, HE; Sørensen, I | 1 |
Long, CI; Vannatta, JB | 1 |
Morton, LP; Rayner, BL; Reynolds, L; Zent, R | 1 |
Anwar, N; Gokal, R; Merchant, MR; Tooth, JA; Uttley, L; Were, A | 1 |
Klaus, G; Mehls, O; Querfeld, U; Schäfer, F; Soergel, M; Wolf, S | 1 |
Bhandari, S; Sanyal, D | 1 |
Bailie, GR; Eisele, G | 1 |
Fukunari, H; Hojo, I; Inoue, T; Ito, M; Kitago, K; Mishima, Y; Nihei, Z; Yoshida, D | 1 |
Freiman, JP; Graham, DJ; McGoodwin, EB; Reed, TG | 1 |
Gokal, R; Marsden, A; Mistry, CD; Ramsden, R; Tooth, A; Were, AJ | 1 |
Bailie, GR; Eisele, G; Hollister, A; Venezia, RA; Yocum, D | 1 |
Cookson, BD; George, RC; Johnson, AP; Sanyal, D; Williams, AJ | 1 |
Bailie, GR; Eisele, G; Smith, TA | 1 |
Lam, TY; Oreopoulos, DG; Vas, SI | 1 |
Dryden, MS; Jones, NF; Phillips, I | 1 |
Kousta, E; Martinis, G; Pasadakis, P; Thodis, E; Vargemezis, V | 1 |
Charney, DI; Gouge, SF | 2 |
Chagnac, A; Korzets, A; Levi, J; Ori, Y; Zevin, D | 1 |
Boeschoten, EW; Dreschler, WD; Nielsen, FW; Struijk, DG; Tange, RA; van der Hulst, RJ | 1 |
Brandi, L; Ejlersen, E; Haarh, P; Kopp, R; Ladefoged, J; Løkkegaard, H | 1 |
Chan, CY; Cheng, IK; Wong, WT | 1 |
Flanigan, MJ; Lim, VS | 1 |
Johnson, CA | 1 |
Abramowicz, D; Amraoui, Z; Fiers, W; Goldman, M; Moulart, J; Nortier, J; Vandenabeele, P; Vanherweghem, JL | 1 |
Bruce, AW; McGroarty, JA; Reid, G; Schwarz-Faulkner, S | 1 |
Holley, J; Piraino, B; Ray, SM | 1 |
Friedlander, M; Newman, L; Tessman, M | 1 |
Rubin, J | 1 |
Dy, G; Goldstein, SJ; Raja, RM | 1 |
Carmichael, DJ; Rao, GG; Short, A | 1 |
Bailie, GR; Eisele, G; Kowalsky, SF | 1 |
Brown, JM; McNeil, MM; Rihs, JD; Yu, VL | 1 |
Bint, AJ; George, JC; Orr, KE; Stansfield, E; Tapson, JS; Ward, MK | 1 |
Barrett, A; Bennett-Jones, DN; Russell, GI | 1 |
Fraise, AP; Friedland, JS; Iveson, TJ; Oliver, DO; Selkon, JB; Winearls, CG | 1 |
Altmann, P; Brown, J; Cunningham, J; Marsh, F; Shaw, E | 1 |
Boletis, I; Brown, CB; Cohen, GL; el Nahas, AM; Johnson, BF; Moorhead, PJ; Raftery, AT; Williams, AJ | 1 |
Edwards, R; Filik, R; Finch, RG; Wilcox, MH | 1 |
Johnson, CA; Zimmerman, SW | 1 |
Ackrill, P; Bowley, JA; Burnie, J; Fleming, SJ; Oppenheim, BA; Pickering, SJ; Ralston, AJ; Sissons, P | 1 |
Berry, AJ; Ludlam, HA; Phillips, I; Young, AE | 1 |
Coucudis, P; Jafer, H; Jara, F; Kartali, S; Pasadakis, P; Peihaberis, P; Thodis, H; Vargemezis, V | 1 |
Engeseth, S; Johnson, CA; O'Brien, M; Zimmerman, SW | 1 |
Ben-Ezer Gradus, D; Benjamin, J; Chaimovitz, C; Mostoslavski, M; Rapoport, J | 1 |
Adu, D; Beaman, M; McGonigle, RJ; Michael, J; Solaro, L | 1 |
Franklin, DB; Hawkins, SS; Yium, JJ | 1 |
Brown, E; Hendler, E | 1 |
Heaton, A; Walker, RW | 1 |
Bailie, GR; Morton, R; Waldek, S; Yu, R | 1 |
Brown, CB; Cole, DR; Coward, RA; Oliver, M | 1 |
Abel, SR | 1 |
Bluestein, HG; Lim, HW; Markman, M | 1 |
Brumfitt, W; Hamilton-Miller, JM | 1 |
Guay, D; Klicker, R; Pence, T; Peterson, P | 1 |
Ackrill, P; Bowley, JA; Jones, DM; Pickering, SJ; Scantlebury, AJ | 1 |
Atkins, RC; Boyce, NW; Kerr, P; Thomson, NM; Wood, C | 1 |
Apicella, MA; Morse, GD; Walshe, JJ | 1 |
Binswanger, U; König, U; Müller, U | 1 |
Aston, E; Edwards, R; Finch, RG; Whitby, M | 1 |
Bailey, S; Bastani, B; Davis, M; Engels, D; Freer, K; Read, D; Sherman, RA; Westervelt, FB | 1 |
Evans, RC; Holmes, CJ | 1 |
Bailie, GR; Ganguli, L; Keaney, M; Morton, R; Waldek, S | 1 |
Morse, GD; Nairn, DK; Walshe, JJ | 1 |
Dalton, HP; Harford, AM; Polk, RE; Poynor, W; Sica, DA; Tartaglione, T | 1 |
Gilligan, PH; Schwalbe, RS; Stapleton, JT | 1 |
Eykyn, SJ; Goulding, S; Gray, HH | 1 |
Avasthi, PS; Leymon, P; Obermiller, LE; Tzamaloukas, AH | 1 |
Benevent, D; Denis, F; Mounier, M | 1 |
Crump, J; Maskell, R | 1 |
Brauner, L; Kahlmeter, G; Lindholm, T; Simonsen, O | 1 |
Adu, D; Curley, J; Gruer, LD; Michael, J; Turney, JH | 1 |
14 review(s) available for vancomycin and Primary Peritonitis
Article | Year |
---|---|
Vancomycin in peritoneal dialysis: Clinical pharmacology considerations in therapy.
Topics: Anti-Bacterial Agents; Humans; Kidney Failure, Chronic; Peritoneal Dialysis; Peritonitis; Vancomycin | 2020 |
Antimicrobial agents for preventing peritonitis in peritoneal dialysis patients.
Topics: Administration, Intranasal; Administration, Topical; Anti-Bacterial Agents; Anti-Infective Agents, Local; Antibiotic Prophylaxis; Antifungal Agents; Catheter-Related Infections; Device Removal; Humans; Injections, Intravenous; Mupirocin; Mycoses; Peritoneal Dialysis; Peritonitis; Randomized Controlled Trials as Topic; Vancomycin | 2017 |
Peritoneal-dialysis related peritonitis caused by Gordonia species: report of four cases and literature review.
Topics: Actinomycetales Infections; Aged; Anti-Bacterial Agents; Device Removal; Disease Management; Gordonia Bacterium; Humans; Infusions, Parenteral; Kidney Failure, Chronic; Male; Meropenem; Middle Aged; Peritoneal Dialysis, Continuous Ambulatory; Peritonitis; Prosthesis-Related Infections; Recurrence; Thienamycins; Treatment Outcome; Vancomycin | 2014 |
[Emergence of vancomycin-dependent enterococci following glycopeptide therapy: case report and review].
Topics: Bacterial Proteins; Bacteriuria; Carbon-Oxygen Ligases; Cecal Diseases; Ceftriaxone; Citrobacter freundii; Codon, Nonsense; Drug Resistance, Multiple, Bacterial; Drug Therapy, Combination; Electrophoresis, Gel, Pulsed-Field; Enterobacteriaceae Infections; Enterococcus faecium; Female; Gram-Positive Bacterial Infections; Humans; Intestinal Perforation; Liver Transplantation; Methicillin-Resistant Staphylococcus aureus; Middle Aged; Norfloxacin; Peritonitis; Postoperative Complications; Staphylococcal Infections; Teicoplanin; Vancomycin; Vancomycin Resistance | 2009 |
Trichosporon mucoides fungemia in a liver transplant recipient: case report and review.
Topics: Antifungal Agents; Enterococcus faecium; Fatal Outcome; Fungemia; Humans; Immunosuppressive Agents; Liver Transplantation; Male; Middle Aged; Mycoses; Peritonitis; Postoperative Complications; Tacrolimus; Triazoles; Trichosporon; Vancomycin; Vancomycin Resistance | 2009 |
Lactobacillus paracasei continuous ambulatory peritoneal dialysis-related peritonitis and review of the literature.
Topics: Aged; Anti-Bacterial Agents; Gram-Positive Bacterial Infections; Humans; Lactobacillus; Male; Peritoneal Dialysis, Continuous Ambulatory; Peritonitis; Vancomycin | 2003 |
Pasteurella aerogenes hamster bite peritonitis.
Topics: Adolescent; Animals; Bites and Stings; Ceftazidime; Cricetinae; Drug Therapy, Combination; Female; Follow-Up Studies; Humans; Injections, Intraperitoneal; Pasteurella; Pasteurella Infections; Peritonitis; Risk Assessment; Treatment Outcome; Vancomycin | 2004 |
The implications of enterococci for the intensive care unit.
Topics: Aminoglycosides; Anti-Bacterial Agents; beta-Lactams; Clindamycin; Cross Infection; Drug Resistance, Bacterial; Enterococcus; Gram-Positive Bacterial Infections; Humans; Immunocompromised Host; Infection Control; Intensive Care Units; Peritonitis; Risk Factors; Vancomycin | 2007 |
The pharmacokinetics of antibiotics used to treat peritoneal dialysis-associated peritonitis.
Topics: Aminoglycosides; Anti-Bacterial Agents; Cephalosporins; Humans; Kinetics; Microbial Sensitivity Tests; Penicillins; Peritoneal Dialysis; Peritoneal Dialysis, Continuous Ambulatory; Peritonitis; Vancomycin | 1984 |
Infectious complications of peritoneal dialysis.
Topics: Anti-Bacterial Agents; Antibiotic Prophylaxis; Bacteremia; Bacterial Infections; Catheterization; Dialysis Solutions; Drug Resistance, Microbial; Equipment Design; Forecasting; Humans; Macrophages, Peritoneal; Peritoneal Dialysis; Peritonitis; Recurrence; Staphylococcal Infections; Vancomycin | 1997 |
Peritoneal dialysis. Prevention and control of infection.
Topics: Anti-Bacterial Agents; Bacterial Infections; Cephalosporins; Equipment Contamination; Humans; Peritoneal Dialysis, Continuous Ambulatory; Peritonitis; Treatment Outcome; Vancomycin | 2000 |
Continuous ambulatory peritoneal dialysis: a review of its mechanics, advantages, complications, and areas of controversy.
Topics: Anti-Infective Agents; Bacterial Infections; Ciprofloxacin; Humans; Peritoneal Dialysis, Continuous Ambulatory; Peritonitis; Renal Dialysis; Technology Assessment, Biomedical; Vancomycin | 1992 |
Pneumococcal peritonitis complicating CAPD--was the indwelling intrauterine device to blame?
Topics: Drug Therapy, Combination; Female; Glomerulonephritis, Membranoproliferative; Humans; Intrauterine Devices; Middle Aged; Peritoneal Dialysis, Continuous Ambulatory; Peritonitis; Pneumococcal Infections; Vancomycin | 1991 |
Oerskovia xanthineolytica implicated in peritonitis associated with peritoneal dialysis: case report and review of Oerskovia infections in humans.
Topics: Actinomycetales; Actinomycetales Infections; Aged; Bacteriological Techniques; Humans; Male; Peritoneal Dialysis, Continuous Ambulatory; Peritonitis; Vancomycin | 1990 |
27 trial(s) available for vancomycin and Primary Peritonitis
Article | Year |
---|---|
Intraperitoneal Vancomycin Plus Either Oral Moxifloxacin or Intraperitoneal Ceftazidime for the Treatment of Peritoneal Dialysis-Related Peritonitis: A Randomized Controlled Pilot Study.
Topics: Administration, Oral; Anti-Bacterial Agents; Ceftazidime; Drug Therapy, Combination; Female; Fluoroquinolones; Humans; Male; Middle Aged; Moxifloxacin; Peritoneal Dialysis; Peritoneum; Peritonitis; Pilot Projects; Prospective Studies; Vancomycin | 2017 |
Vancomycin pharmacokinetics during continuous ambulatory peritoneal dialysis in patients with peritonitis.
Topics: Aged; Anti-Bacterial Agents; Ceftazidime; Female; Humans; Injections, Intraperitoneal; Male; Middle Aged; Peritoneal Dialysis, Continuous Ambulatory; Peritonitis; Vancomycin | 2011 |
Protective effect of N-acetylcysteine from drug-induced ototoxicity in uraemic patients with CAPD peritonitis.
Topics: Acetylcysteine; Amikacin; Anti-Bacterial Agents; Ear Diseases; Free Radical Scavengers; Humans; Peritoneal Dialysis, Continuous Ambulatory; Peritonitis; Prospective Studies; Vancomycin | 2011 |
Efficacy of a non-vancomycin-based peritoneal dialysis peritonitis protocol.
Topics: Adult; Aged; Anti-Bacterial Agents; Cefazolin; Drug Resistance, Bacterial; Drug Therapy, Combination; Female; Gentamicins; Humans; Injections, Intraperitoneal; Kidney Failure, Chronic; Male; Middle Aged; Outpatients; Peritoneal Dialysis; Peritonitis; Prospective Studies; Vancomycin | 2005 |
Definition of the role of enterococcus in intraabdominal infection: analysis of a prospective randomized trial.
Topics: Abscess; Adult; Anti-Infective Agents; Bacteremia; Ciprofloxacin; Double-Blind Method; Drug Resistance, Microbial; Drug Therapy, Combination; Enterococcus; Female; Gram-Positive Bacterial Infections; Humans; Logistic Models; Male; Metronidazole; Middle Aged; Peritonitis; Prospective Studies; Sepsis; Treatment Failure; Vancomycin | 1995 |
A prospective, randomized study of the comparative safety and efficacy of intraperitoneal imipenem versus vancomycin and netilmicin in the treatment of peritonitis on CAPD.
Topics: Drug Therapy, Combination; Female; Humans; Imipenem; Male; Middle Aged; Netilmicin; Peritoneal Dialysis, Continuous Ambulatory; Peritonitis; Prospective Studies; Vancomycin | 1995 |
Intraperitoneal vancomycin/oral pefloxacin versus intraperitoneal vancomycin/gentamicin in the treatment of continuous ambulatory peritoneal dialysis peritonitis.
Topics: Administration, Oral; Aged; Drug Therapy, Combination; Female; Gentamicins; Humans; Male; Middle Aged; Pefloxacin; Peritoneal Dialysis, Continuous Ambulatory; Peritonitis; Treatment Failure; Vancomycin | 1993 |
Treatment of peritoneal dialysis-associated peritonitis with continuous versus intermittent vancomycin/teicoplanin and ceftazidime in children: preliminary results of a prospective randomized trial. Members of APN Arbeitsgemeinschaft Paidiatrische Nephrol
Topics: Anti-Bacterial Agents; Bacterial Infections; Ceftazidime; Cephalosporins; Child; Drug Therapy, Combination; Humans; Peritoneal Dialysis; Peritoneal Dialysis, Continuous Ambulatory; Peritonitis; Prospective Studies; Recurrence; Teicoplanin; Vancomycin | 1995 |
[Does intraperitoneal vancomycin induce chemical peritonitis?].
Topics: Adult; Aged; Female; Humans; Injections, Intraperitoneal; Male; Middle Aged; Peritoneal Dialysis; Peritonitis; Vancomycin | 1995 |
Cefazolin and netilmycin versus vancomycin and ceftazidime in the treatment of CAPD peritonitis.
Topics: Cefazolin; Ceftazidime; Drug Therapy, Combination; Humans; Middle Aged; Netilmicin; Peritoneal Dialysis, Continuous Ambulatory; Peritonitis; Prospective Studies; Treatment Failure; Vancomycin | 1997 |
Oral ciprofloxacin to treat bacterial peritonitis associated with peritoneal dialysis.
Topics: Administration, Oral; Anti-Bacterial Agents; Anti-Infective Agents; Ciprofloxacin; Drug Therapy, Combination; Gram-Negative Bacterial Infections; Humans; Peritoneal Dialysis; Peritonitis; Vancomycin | 1997 |
Intermittent versus continuous intraperitoneal glycopeptide/ceftazidime treatment in children with peritoneal dialysis-associated peritonitis. The Mid-European Pediatric Peritoneal Dialysis Study Group (MEPPS).
Topics: Adolescent; Adult; Anti-Bacterial Agents; Ceftazidime; Cephalosporins; Child; Child, Preschool; Drug Therapy, Combination; Humans; Infant; Injections, Intraperitoneal; Peritoneal Dialysis; Peritonitis; Prospective Studies; Teicoplanin; Vancomycin | 1999 |
Preoperative vancomycin prophylaxis for newly placed peritoneal dialysis catheters prevents postoperative peritonitis.
Topics: Adolescent; Adult; Aged; Aged, 80 and over; Anti-Bacterial Agents; Antibiotic Prophylaxis; Catheters, Indwelling; Cefazolin; Cephalosporins; Female; Humans; Male; Middle Aged; Peritoneal Dialysis; Peritonitis; Prospective Studies; Vancomycin | 2000 |
Role of preoperative antibiotic prophylaxis in preventing postoperative peritonitis in newly placed peritoneal dialysis catheters.
Topics: Adolescent; Adult; Aged; Aged, 80 and over; Anti-Bacterial Agents; Antibiotic Prophylaxis; Catheters, Indwelling; Cefazolin; Cephalosporins; Female; Humans; Male; Middle Aged; Peritoneal Dialysis; Peritonitis; Postoperative Complications; Prospective Studies; Urinary Catheterization; Vancomycin | 2000 |
Initial treatment of peritoneal dialysis peritonitis without vancomycin with a once-daily cefazolin-based regimen.
Topics: Adult; Aged; Aged, 80 and over; Cefazolin; Drug Administration Schedule; Drug Therapy, Combination; Female; Gentamicins; Humans; Male; Middle Aged; Peritoneal Dialysis; Peritoneal Dialysis, Continuous Ambulatory; Peritonitis; Treatment Outcome; Vancomycin | 2001 |
Cefepime versus vancomycin plus netilmicin therapy for continuous ambulatory peritoneal dialysis-associated peritonitis.
Topics: Adult; Aged; Anti-Bacterial Agents; Cefepime; Cephalosporins; Female; Gentamicins; Gram-Negative Bacteria; Gram-Positive Bacteria; Humans; Male; Middle Aged; Netilmicin; Peritoneal Dialysis, Continuous Ambulatory; Peritonitis; Prospective Studies; Treatment Outcome; Vancomycin | 2001 |
Imipenem versus netilmicin and vancomycin in the treatment of CAPD peritonitis.
Topics: Female; Humans; Imipenem; Male; Middle Aged; Peritoneal Dialysis, Continuous Ambulatory; Peritonitis; Prospective Studies; Recurrence; Vancomycin | 1992 |
Is initial (24 hours) lavage necessary in treatment of CAPD peritonitis?
Topics: Acute Disease; Bacterial Infections; Humans; Netilmicin; Peritoneal Dialysis, Continuous Ambulatory; Peritoneal Lavage; Peritonitis; Recurrence; Vancomycin | 1991 |
A randomised prospective comparison of oral ofloxacin and intraperitoneal vancomycin plus aztreonam in the treatment of bacterial peritonitis complicating continuous ambulatory peritoneal dialysis (CAPD).
Topics: Administration, Oral; Aztreonam; Bacterial Infections; Drug Therapy, Combination; Humans; Ofloxacin; Peritoneal Dialysis, Continuous Ambulatory; Peritonitis; Vancomycin | 1991 |
Initial treatment of dialysis associated peritonitis: a controlled trial of vancomycin versus cefazolin.
Topics: Adult; Cefazolin; Female; Humans; Infusions, Parenteral; Male; Middle Aged; Peritoneal Dialysis, Continuous Ambulatory; Peritonitis; Recurrence; Vancomycin | 1991 |
A comparison between oral ciprofloxacin and intraperitoneal vancomycin and netilmicin in CAPD peritonitis.
Topics: Administration, Oral; Adult; Aged; Aged, 80 and over; Ciprofloxacin; Female; Humans; Injections, Intraperitoneal; Male; Middle Aged; Netilmicin; Peritoneal Dialysis, Continuous Ambulatory; Peritonitis; Prospective Studies; Vancomycin | 1990 |
A comparison between oral ciprofloxacin and intra-peritoneal vancomycin and gentamicin in the treatment of CAPD peritonitis.
Topics: Administration, Oral; Adult; Ciprofloxacin; Gentamicins; Humans; Injections, Intraperitoneal; Peritoneal Dialysis, Continuous Ambulatory; Peritonitis; Prospective Studies; Remission Induction; Vancomycin | 1990 |
A comparison between intraperitoneal ciprofloxacin and intraperitoneal vancomycin and gentamicin in the treatment of peritonitis associated with continuous ambulatory peritoneal dialysis (CAPD).
Topics: Adult; Aged; Ciprofloxacin; Female; Gentamicins; Humans; Injections, Intraperitoneal; Male; Middle Aged; Peritoneal Dialysis, Continuous Ambulatory; Peritonitis; Vancomycin | 1990 |
Tenckhoff catheter replacement or intraperitoneal urokinase: a randomised trial in the management of recurrent continuous ambulatory peritoneal dialysis (CAPD) peritonitis.
Topics: Catheters, Indwelling; Female; Gentamicins; Humans; Infusions, Parenteral; Kidney Failure, Chronic; Male; Middle Aged; Peritoneal Dialysis, Continuous Ambulatory; Peritonitis; Recurrence; Urokinase-Type Plasminogen Activator; Vancomycin | 1989 |
Vancomycin therapy for gram-positive peritonitis in patients on CAPD.
Topics: Drug Administration Schedule; Female; Humans; Infusions, Intravenous; Infusions, Parenteral; Male; Peritoneal Dialysis, Continuous Ambulatory; Peritonitis; Recurrence; Staphylococcal Infections; Streptococcal Infections; Vancomycin | 1989 |
Intraperitoneal teicoplanin in the treatment of peritonitis associated with continuous ambulatory peritoneal dialysis.
Topics: Anti-Bacterial Agents; Clinical Trials as Topic; Glycopeptides; Humans; Injections, Intraperitoneal; Microbial Sensitivity Tests; Peritoneal Dialysis, Continuous Ambulatory; Peritonitis; Random Allocation; Teicoplanin; Vancomycin | 1988 |
Intraperitoneal (IP) vancomycin therapy for CAPD peritonitis--a prospective, randomized comparison of intermittent v continuous therapy.
Topics: Drug Administration Schedule; Humans; Peritoneal Dialysis, Continuous Ambulatory; Peritonitis; Prospective Studies; Random Allocation; Vancomycin | 1988 |
181 other study(ies) available for vancomycin and Primary Peritonitis
Article | Year |
---|---|
DNA binding ligands with in vivo efficacy in murine models of bacterial infection: optimization of internal aromatic amino acids.
Topics: Amino Acids, Aromatic; Animals; Anti-Bacterial Agents; Disease Models, Animal; DNA; Ligands; Lung Diseases; Mice; Peritonitis; Staphylococcal Infections; Staphylococcus aureus; Streptococcal Infections; Streptococcus pneumoniae | 2004 |
Rapid bactericidal activity of daptomycin against methicillin-resistant and methicillin-susceptible Staphylococcus aureus peritonitis in mice as measured with bioluminescent bacteria.
Topics: Acetamides; Animals; Anti-Bacterial Agents; Colony Count, Microbial; Daptomycin; Female; Linezolid; Luminescent Measurements; Methicillin Resistance; Mice; Microbial Sensitivity Tests; Neutropenia; Oxazolidinones; Peritonitis; Staphylococcus aureus | 2007 |
Cotransfer of antibiotic resistance genes and a hylEfm-containing virulence plasmid in Enterococcus faecium.
Topics: Animals; Anti-Bacterial Agents; Bacterial Proteins; Drug Resistance, Multiple, Bacterial; Enterococcus faecium; Female; Humans; Mice; Microbial Sensitivity Tests; Peritonitis; Plasmids; Vancomycin Resistance; Virulence | 2009 |
Semisynthesis of Platensimycin Derivatives with Antibiotic Activities in Mice via Suzuki-Miyaura Cross-Coupling Reactions.
Topics: Adamantane; Aminobenzoates; Anilides; Animals; Anti-Bacterial Agents; Disease Models, Animal; Male; Methicillin-Resistant Staphylococcus aureus; Microbial Sensitivity Tests; Molecular Docking Simulation; Peritonitis; Staphylococcal Infections | 2018 |
Nature-Inspired (di)Azine-Bridged Bisindole Alkaloids with Potent Antibacterial
Topics: Alkaloids; Animals; Anti-Bacterial Agents; Cell Line; Cell Survival; Female; Gram-Negative Bacteria; Gram-Positive Bacteria; Humans; Indoles; Methicillin-Resistant Staphylococcus aureus; Mice; Mice, Inbred BALB C; Microbial Sensitivity Tests; Peritonitis; Pyruvate Kinase; Rabbits | 2020 |
Intraperitoneal vancomycin-induced immune thrombocytopenia.
Topics: Anti-Bacterial Agents; Dexamethasone; Humans; Peritonitis; Purpura, Thrombocytopenic, Idiopathic; Renal Dialysis; Thrombocytopenia; Vancomycin | 2022 |
Evaluation of intraperitoneal vancomycin in peritoneal dialysis-associated peritonitis.
Topics: Adult; Anti-Bacterial Agents; Drug Monitoring; Humans; Peritoneal Dialysis; Peritonitis; Retrospective Studies; Vancomycin | 2022 |
Serum vancomycin levels predict the short-term adverse outcomes of peritoneal dialysis-associated peritonitis.
Topics: Anti-Bacterial Agents; Humans; Peritoneal Dialysis; Peritonitis; Retrospective Studies; Vancomycin | 2023 |
Risk Factors and Pathogen Spectrum in Continuous Ambulatory Peritoneal Dialysis-Associated Peritonitis: A Single Center Retrospective Study.
Topics: Anti-Bacterial Agents; Bacteria; C-Reactive Protein; Drug Resistance, Bacterial; Globulins; Humans; Linezolid; Microbial Sensitivity Tests; Peritoneal Dialysis, Continuous Ambulatory; Peritonitis; Retrospective Studies; Risk Factors; Teicoplanin; Vancomycin | 2022 |
Three Weeks of Treatment Induced Long-term Remission in a Patient with Micrococcus luteus-related Peritonitis.
Topics: Aged; Anti-Bacterial Agents; Ceftazidime; Female; Humans; Micrococcus luteus; Peritonitis; Vancomycin | 2023 |
Predictors of serum vancomycin levels in peritoneal dialysis-associated peritonitis.
Topics: Adult; Anti-Bacterial Agents; Humans; Peritoneal Dialysis; Peritoneum; Peritonitis; Retrospective Studies; Vancomycin | 2023 |
Sepsis induced bacterial peritonitis caused by Granulicatella adiacens.
Topics: Adult; Anti-Bacterial Agents; Carnobacteriaceae; Gram-Positive Bacterial Infections; Humans; Male; Peritonitis; Sepsis; Staphylococcus aureus; Vancomycin | 2019 |
Peritoneal GATA6+ macrophages function as a portal for Staphylococcus aureus dissemination.
Topics: Animals; Female; GATA6 Transcription Factor; Macrophages, Peritoneal; Male; Mice; Peritonitis; Sepsis; Staphylococcal Infections; Staphylococcus aureus; Vancomycin | 2019 |
Staphylococcus sciuri peritonitis in a patient on peritoneal dialysis.
Topics: Aged; Anti-Bacterial Agents; Ceftriaxone; Humans; Male; Peritoneal Dialysis; Peritonitis; Staphylococcal Infections; Staphylococcus; Vancomycin | 2020 |
Outcome and Adequacy of Empirical Antibiotherapy in Post-Operative Peritonitis: A Retrospective Study.
Topics: Adult; Aged; Aged, 80 and over; Aminoglycosides; Anastomotic Leak; Anti-Bacterial Agents; Ascitic Fluid; Clavulanic Acids; Cohort Studies; Culture Techniques; Digestive System Surgical Procedures; Disk Diffusion Antimicrobial Tests; Drug Resistance, Multiple, Bacterial; Female; Fluoroquinolones; Hospital Mortality; Humans; Imipenem; Male; Microbial Sensitivity Tests; Middle Aged; Multivariate Analysis; Peritonitis; Piperacillin, Tazobactam Drug Combination; Postoperative Complications; Prognosis; Retrospective Studies; Surgical Wound Infection; Ticarcillin; Treatment Outcome; Vancomycin | 2020 |
Intraperitoneal vancomycin for peritoneal dialysis-associated peritonitis in children: Evaluation of loading dose guidelines.
Topics: Adult; Bayes Theorem; Child; Humans; Peritoneal Dialysis; Peritonitis; Retrospective Studies; Vancomycin | 2021 |
Clostridium tertium Peritonitis and Bacteremia in a Neonate With Congenital Intestinal Atresia: A Case Report.
Topics: Anti-Bacterial Agents; Bacteremia; Clostridium Infections; Clostridium tertium; Female; Humans; Infant, Newborn; Meropenem; Peritonitis; Splenic Infarction; Vancomycin | 2021 |
Topics: Anti-Bacterial Agents; Child; Gram-Positive Bacteria; Humans; Infant; Male; Peritoneal Dialysis; Peritonitis; Streptococcus salivarius; Vancomycin | 2021 |
Complicated peritoneal dialysis-associated peritonitis caused by Brevibacterium.
Topics: Aged; Anti-Bacterial Agents; Brevibacterium; Gram-Positive Bacterial Infections; Humans; Male; Peritoneal Dialysis; Peritonitis; Vancomycin | 2021 |
Severe eosinophilic peritonitis caused by intraperitoneal vancomycin administration.
Topics: Anti-Bacterial Agents; Humans; Male; Middle Aged; Peritoneal Dialysis; Peritoneal Dialysis, Continuous Ambulatory; Peritonitis; Vancomycin | 2021 |
Determination of Vancomycin in Human Serum by Cyclodextrin-Micellar Electrokinetic Capillary Chromatography (CD-MEKC) and Application for PDAP Patients.
Topics: Chromatography, Micellar Electrokinetic Capillary; Cyclodextrins; Drug Monitoring; Humans; Hydrogen-Ion Concentration; Peritoneal Dialysis; Peritonitis; Vancomycin | 2017 |
Treatment of Enterococcal Peritonitis in Peritoneal Dialysis Patients by Oral Amoxicillin or Intra-Peritoneal Vancomcyin: a Retrospective Study.
Topics: Adult; Aged; Amoxicillin; Enterococcus; Female; Humans; Male; Middle Aged; Peritoneal Dialysis; Peritonitis; Retrospective Studies; Treatment Outcome; Vancomycin | 2017 |
Neisseria mucosa Peritonitis in the Setting of a Migrated Intrauterine Device.
Topics: Adult; Female; Humans; Intrauterine Devices; Neisseria mucosa; Neisseriaceae Infections; Peritoneal Dialysis; Peritonitis; Vancomycin | 2018 |
Micrococcus aloeverae - A Rare Cause of Peritoneal Dialysis-Related Peritonitis Confirmed by 16S rRNA Gene Sequencing.
Topics: Actinomycetales Infections; Anti-Bacterial Agents; Dialysis Solutions; Female; Humans; Leukocyte Count; Micrococcus; Middle Aged; Peritoneal Dialysis, Continuous Ambulatory; Peritonitis; RNA, Ribosomal, 16S; Sequence Analysis, RNA; Vancomycin | 2019 |
A recombinant fungal defensin-like peptide-P2 combats multidrug-resistant Staphylococcus aureus and biofilms.
Topics: Animals; Anti-Bacterial Agents; Biofilms; Chemokine CCL2; Defensins; Drug Discovery; Drug Resistance, Multiple, Bacterial; Female; Interleukin-10; Methicillin-Resistant Staphylococcus aureus; Mice; Microbial Sensitivity Tests; Peritonitis; Pichia; RAW 264.7 Cells; Staphylococcal Infections; Tumor Necrosis Factor-alpha; Vancomycin | 2019 |
Intraperitoneal vancomycin in neonates during peritoneal dialysis: A case report.
Topics: Anti-Bacterial Agents; Humans; Infant, Newborn; Male; Peritoneal Dialysis; Peritoneal Dialysis, Continuous Ambulatory; Peritonitis; Vancomycin | 2019 |
The pathogen spectrum and resistance in patients with peritoneal dialysis-associated peritonitis: A single-center, observational clinical study
.
Topics: Adolescent; Adult; Aged; Aged, 80 and over; Anti-Bacterial Agents; Antifungal Agents; Bacterial Infections; Cefazolin; Ceftriaxone; Drug Resistance, Bacterial; Female; Gram-Negative Bacteria; Gram-Negative Bacterial Infections; Gram-Positive Bacterial Infections; Gram-Positive Cocci; Humans; Imipenem; Itraconazole; Male; Microbial Sensitivity Tests; Middle Aged; Mycoses; Peritoneal Dialysis; Peritonitis; Vancomycin; Voriconazole; Young Adult | 2019 |
Efficacy of a synthetic antimicrobial peptidomimetic versus vancomycin in a Staphylococcus epidermidis device-related murine peritonitis model.
Topics: Animals; Anti-Bacterial Agents; Bacterial Load; Catheter-Related Infections; Disease Models, Animal; Female; Mice; Mice, Inbred BALB C; Peptidomimetics; Peritoneal Dialysis; Peritonitis; Staphylococcal Infections; Staphylococcus epidermidis; Treatment Outcome; Vancomycin | 2013 |
Peritonitis caused by Rothia mucilaginosa in a peritoneal dialysis patient.
Topics: Actinomycetales Infections; Administration, Oral; Adult; Drug Therapy, Combination; Female; Humans; Infusions, Parenteral; Micrococcaceae; Peritoneal Dialysis; Peritonitis; Rifampin; Treatment Outcome; Vancomycin | 2013 |
Peritoneal dialysis-related peritonitis due to coagulase-negative Staphylococcus: a review of 115 cases in a Brazilian center.
Topics: Adult; Aged; Anti-Bacterial Agents; Bacterial Proteins; Biofilms; Brazil; Coagulase; Female; Humans; Incidence; Male; Middle Aged; Oxacillin; Penicillin Resistance; Peritoneal Dialysis; Peritonitis; Staphylococcal Infections; Staphylococcus; Vancomycin | 2014 |
Anthracimycin activity against contemporary methicillin-resistant Staphylococcus aureus.
Topics: Animals; Anti-Bacterial Agents; HeLa Cells; Humans; Methicillin; Methicillin Resistance; Methicillin-Resistant Staphylococcus aureus; Mice; Microbial Sensitivity Tests; Molecular Structure; Peritonitis; Polyketides; Staphylococcal Infections; Vancomycin; Vancomycin Resistance | 2014 |
Microbacterium spp. as a cause of peritoneal-dialysis-related peritonitis in two patients.
Topics: Acinetobacter; Actinobacteria; Aged, 80 and over; Anti-Bacterial Agents; Cephalosporins; Ciprofloxacin; Female; Humans; Microbial Sensitivity Tests; Middle Aged; Penicillins; Peritoneal Dialysis; Peritonitis; Spectrometry, Mass, Matrix-Assisted Laser Desorption-Ionization; Vancomycin | 2016 |
[Peritoneal dialysis-related infections].
Topics: Aminoglycosides; Anti-Bacterial Agents; Catheters, Indwelling; Cephalosporins; Drug Therapy, Combination; Humans; Patient Education as Topic; Peritoneal Dialysis; Peritonitis; Staphylococcal Infections; Treatment Outcome; Vancomycin | 2014 |
Staphylococcus lentus peritonitis: a case report.
Topics: Animals; Anti-Bacterial Agents; Catheters, Indwelling; Humans; Male; Middle Aged; Peritoneal Dialysis; Peritonitis; Staphylococcal Infections; Staphylococcus; Vancomycin; Zoonoses | 2014 |
Linezolid and vancomycin-resistant Enterococcus faecium peritonitis in a child after liver transplantation.
Topics: Biliary Atresia; Child, Preschool; Coinfection; Cross Infection; Drug Resistance, Multiple, Bacterial; Enterococcus faecium; Gram-Positive Bacterial Infections; Humans; Linezolid; Liver Transplantation; Male; Peritonitis; Portoenterostomy, Hepatic; Postoperative Complications; Pseudomonas Infections; RNA, Bacterial; RNA, Ribosomal, 23S; Vancomycin | 2015 |
Residual renal function in patients on peritoneal dialysis: effect of peritonitis episodes.
Topics: Adult; Aged; Diabetic Nephropathies; Female; Glomerular Filtration Rate; Humans; Kidney; Kidney Failure, Chronic; Kidney Transplantation; Male; Middle Aged; Peritoneal Dialysis; Peritonitis; Recurrence; Renal Dialysis; Retrospective Studies; Tobramycin; Vancomycin | 2014 |
Rhodococcus equi peritonitis in continuous ambulatory peritoneal dialysis: a first in Australia.
Topics: Actinomycetales Infections; Adult; Anti-Infective Agents; Australia; Azithromycin; Ciprofloxacin; Drug Therapy, Combination; Follow-Up Studies; Humans; Kidney Failure, Chronic; Male; Peritoneal Dialysis, Continuous Ambulatory; Peritonitis; Rhodococcus equi; Treatment Outcome; Vancomycin | 2015 |
Lactobacillus casei Peritonitis in Peritoneal Dialysis: A Rare Case and Literature Review.
Topics: Aged; Anti-Bacterial Agents; Antifungal Agents; Ascitic Fluid; Candida albicans; Fluconazole; Humans; Infusions, Parenteral; Kidney Failure, Chronic; Lacticaseibacillus casei; Male; Microbial Sensitivity Tests; Peritoneal Dialysis, Continuous Ambulatory; Peritonitis; Renal Dialysis; Treatment Outcome; Vancomycin | 2016 |
Vancomycin-induced eosinophilic peritonitis.
Topics: Adult; Anti-Bacterial Agents; Eosinophilia; Female; Humans; Infusions, Parenteral; Peritonitis; Vancomycin | 2016 |
Peritonitis in children with automated peritoneal dialysis: a single-center study of a 10-year experience.
Topics: Adolescent; Anti-Bacterial Agents; Ceftazidime; Child; Child, Preschool; Female; Greece; Humans; Incidence; Infant; Injections, Intraperitoneal; Kidney Failure, Chronic; Male; Peritoneal Dialysis; Peritonitis; Retrospective Studies; Staphylococcal Infections; Staphylococcus aureus; Treatment Outcome; Vancomycin; Young Adult | 2016 |
Comparative efficacies of daptomycin, vancomycin, and linezolid in experimental enterococcal peritonitis.
Topics: Animals; Anti-Bacterial Agents; Biofilms; Daptomycin; Disease Models, Animal; Enterococcus; Female; Gram-Positive Bacterial Infections; Linezolid; Mice; Mice, Inbred C57BL; Peritonitis; Vancomycin | 2017 |
Enterococcus: not an innocent bystander in cirrhotic patients with spontaneous bacterial peritonitis.
Topics: Aged; Ampicillin; Anti-Bacterial Agents; Ascites; Cephalosporins; Cohort Studies; Enterococcus; Female; Gentamicins; Gram-Positive Bacterial Infections; Humans; Korea; Liver Cirrhosis; Male; Microbial Sensitivity Tests; Middle Aged; Peritonitis; Retrospective Studies; Treatment Outcome; Vancomycin | 2009 |
Relapsing peritonitis with Corynebacterium aquaticum in a boy receiving automated peritoneal dialysis.
Topics: Adolescent; Anti-Bacterial Agents; Cefazolin; Ceftazidime; Corynebacterium; Corynebacterium Infections; Drug Combinations; Humans; Male; Microbial Sensitivity Tests; Peritoneal Dialysis, Continuous Ambulatory; Peritonitis; Recurrence; Treatment Outcome; Vancomycin | 2009 |
Successful use of intraperitoneal daptomycin in the treatment of vancomycin-resistant enterococcus peritonitis.
Topics: Adult; Daptomycin; Enterococcus faecium; Female; Gram-Positive Bacterial Infections; Humans; Injections, Intraperitoneal; Middle Aged; Peritonitis; Treatment Outcome; Vancomycin; Vancomycin Resistance | 2009 |
Recurrent and relapsing peritonitis: causative organisms and response to treatment.
Topics: Adult; Aged; Anti-Bacterial Agents; Cefazolin; Ceftazidime; Female; Gentamicins; Gram-Negative Bacterial Infections; Gram-Positive Bacterial Infections; Humans; Logistic Models; Male; Middle Aged; Netilmicin; Peritoneal Dialysis; Peritonitis; Prognosis; Recurrence; Retrospective Studies; Risk Factors; Vancomycin | 2009 |
Streptococcal peritonitis in Australian peritoneal dialysis patients: predictors, treatment and outcomes in 287 cases.
Topics: Aged; Anti-Bacterial Agents; Australia; Cephalosporins; Female; Follow-Up Studies; Humans; Logistic Models; Male; Middle Aged; Peritoneal Dialysis; Peritonitis; Predictive Value of Tests; Prevalence; Retrospective Studies; Risk Factors; Streptococcal Infections; Treatment Outcome; Vancomycin | 2009 |
Potential therapeutic failure of generic vancomycin in a liver transplant patient with MRSA peritonitis and bacteremia.
Topics: Anti-Bacterial Agents; Bacteremia; Drugs, Generic; Humans; Liver Transplantation; Male; Methicillin-Resistant Staphylococcus aureus; Middle Aged; Peritonitis; Staphylococcal Infections; Treatment Outcome; Vancomycin | 2009 |
Influence of the AtlE autolysin on the activity of cell wall-active agents against Staphylococcus epidermidis.
Topics: Animals; Anti-Bacterial Agents; Bacterial Infections; Bacterial Proteins; Cell Wall; Cloxacillin; Colony Count, Microbial; Mice; Microbial Viability; N-Acetylmuramoyl-L-alanine Amidase; Peritonitis; Staphylococcus epidermidis; Survival Analysis; Vancomycin | 2010 |
Outcome of accidental peritoneal dialysis catheter holes or tip exposure.
Topics: Adolescent; Anti-Bacterial Agents; Catheter-Related Infections; Catheterization; Child; Child, Preschool; Humans; Infant; Peritoneal Dialysis; Peritonitis; Prevalence; Vancomycin; Young Adult | 2010 |
Correlation between hearing loss and peritonitis frequency and administration of ototoxic intraperitoneal antibiotics in patients with CAPD.
Topics: Amikacin; Aminoglycosides; Anti-Bacterial Agents; Audiometry, Pure-Tone; Case-Control Studies; Cephalothin; Female; Hearing Loss; Humans; Male; Middle Aged; Peritoneal Dialysis, Continuous Ambulatory; Peritonitis; Regression Analysis; Risk Factors; Severity of Illness Index; Statistics, Nonparametric; Vancomycin | 2010 |
In vitro and in vivo activities of linezolid alone and combined with vancomycin and imipenem against Staphylococcus aureus with reduced susceptibility to glycopeptides.
Topics: Acetamides; Animals; Ascitic Fluid; Bacteremia; Disease Models, Animal; Drug Resistance, Multiple, Bacterial; Drug Synergism; Drug Therapy, Combination; Glycopeptides; Imipenem; Linezolid; Methicillin Resistance; Methicillin-Resistant Staphylococcus aureus; Mice; Mice, Inbred C57BL; Microbial Sensitivity Tests; Oxazolidinones; Peritonitis; Staphylococcal Infections; Staphylococcus aureus; Vancomycin | 2010 |
Efficacy of fosfomycin and its combination with linezolid, vancomycin and imipenem in an experimental peritonitis model caused by a Staphylococcus aureus strain with reduced susceptibility to vancomycin.
Topics: Acetamides; Animals; Anti-Bacterial Agents; Ascitic Fluid; Bacteremia; Bacterial Load; Disease Models, Animal; Drug Therapy, Combination; Female; Fosfomycin; Humans; Imipenem; Linezolid; Mice; Mice, Inbred C57BL; Microbial Sensitivity Tests; Oxazolidinones; Peritonitis; Staphylococcal Infections; Treatment Outcome; Vancomycin | 2011 |
CAPD peritonitis after colonoscopy: follow the guidelines.
Topics: Aged; Anti-Bacterial Agents; Antibiotic Prophylaxis; Ceftazidime; Colonoscopy; Female; Gentamicins; Humans; Iatrogenic Disease; Male; Peritoneal Dialysis, Continuous Ambulatory; Peritonitis; Practice Guidelines as Topic; Vancomycin | 2010 |
Peritonitis after gynecological and gastroscopic examinations in a peritoneal dialysis patient.
Topics: Amikacin; Anti-Bacterial Agents; Antibiotic Prophylaxis; Cilastatin; Cilastatin, Imipenem Drug Combination; Drug Combinations; Enterococcus; Female; Gastroscopy; Gynecological Examination; Humans; Imipenem; Middle Aged; Peritoneal Dialysis; Peritonitis; Secondary Prevention; Treatment Outcome; Vancomycin | 2010 |
Peritoneal dialysis-related peritonitis caused by vancomycin-resistant Enterococcus faecium.
Topics: Anti-Bacterial Agents; Drug Resistance, Bacterial; Enterococcus faecium; Gram-Positive Bacterial Infections; Humans; Kidney Failure, Chronic; Male; Middle Aged; Peritoneal Dialysis, Continuous Ambulatory; Peritonitis; Vancomycin | 2011 |
Coagulase-negative staphylococcal peritonitis: outcomes of cephalosporin-resistant strains.
Topics: Anti-Bacterial Agents; Cefazolin; Ceftazidime; Cephalosporin Resistance; Coagulase; Humans; Peritoneal Dialysis; Peritonitis; Recurrence; Staphylococcal Infections; Staphylococcus; Tobramycin; Vancomycin | 2010 |
An unusual cause of continuous ambulatory peritoneal dialysis-associated outpatient peritonitis: Stenotrophomonas maltophilia.
Topics: Anti-Bacterial Agents; Ceftazidime; Cross Infection; Drug Therapy, Combination; Female; Gram-Negative Bacterial Infections; Humans; Middle Aged; Outpatients; Peritoneal Dialysis, Continuous Ambulatory; Peritonitis; Stenotrophomonas maltophilia; Vancomycin | 2011 |
Chemical peritonitis in a patient treated with icodextrin and intraperitoneal vancomycin.
Topics: Abdominal Pain; Adult; Bacterial Infections; Ceftazidime; Diabetic Nephropathies; Diagnosis, Differential; Drug Therapy, Combination; Glucans; Glucose; Humans; Icodextrin; Infusions, Intravenous; Injections, Intraperitoneal; Male; Neutrophils; Peritoneal Dialysis; Peritonitis; Renal Dialysis; Vancomycin | 2011 |
Peritonitis in recent years: clinical findings and predictors of treatment response of 170 episodes at a single Brazilian center.
Topics: Age Factors; Aged; Amikacin; Anti-Bacterial Agents; Brazil; Cefazolin; Ceftazidime; Drug Resistance, Bacterial; Enterobacteriaceae Infections; Enterococcus; Female; Humans; Male; Middle Aged; Multivariate Analysis; Oxacillin; Peritoneal Dialysis; Peritonitis; Recurrence; Staphylococcal Infections; Streptococcal Infections; Survival Analysis; Treatment Outcome; Vancomycin | 2012 |
Peritoneal dialysis-related peritonitis due to Staphylococcus aureus: a single-center experience over 15 years.
Topics: Adult; Brazil; Female; Humans; Logistic Models; Male; Microbial Sensitivity Tests; Middle Aged; Odds Ratio; Peritoneal Dialysis; Peritonitis; Staphylococcus aureus; Vancomycin; Virulence Factors; Young Adult | 2012 |
Infection regulates pro-resolving mediators that lower antibiotic requirements.
Topics: Animals; Anti-Bacterial Agents; Docosahexaenoic Acids; Escherichia coli; Escherichia coli Infections; Humans; Hypothermia; Macrophages; Male; Mice; Mice, Inbred C57BL; Microbial Viability; Neutrophils; Peritonitis; Phagocytosis; Skin Diseases; Staphylococcal Infections; Staphylococcus aureus; Vancomycin | 2012 |
Temporal trends in peritonitis rates, microbiology and outcomes: the major clinical complication of peritoneal dialysis.
Topics: Adult; Anti-Bacterial Agents; Antifungal Agents; Bacteria; Bacterial Infections; Ceftazidime; Cohort Studies; Female; Fluconazole; Humans; Kidney Failure, Chronic; Male; Middle Aged; Mupirocin; Peritoneal Dialysis; Peritonitis; Treatment Outcome; Vancomycin | 2012 |
Peritonitis due to Leuconostoc species in a child receiving peritoneal dialysis.
Topics: Ampicillin; Anti-Bacterial Agents; Child; Female; Gram-Positive Bacterial Infections; Humans; Immunosuppressive Agents; Leuconostoc; Penicillins; Peritoneal Dialysis; Peritonitis; Vancomycin | 2002 |
Activity of tigecycline (GAR-936), a novel glycylcycline, against Enterococci in the mouse peritonitis model.
Topics: Animals; Anti-Bacterial Agents; Disease Models, Animal; Enterococcus faecalis; Enterococcus faecium; Female; Mice; Mice, Inbred ICR; Microbial Sensitivity Tests; Minocycline; Peritonitis; Tetracyclines; Tigecycline; Vancomycin | 2003 |
Pharmacology of novel heteroaromatic polycycle antibacterials.
Topics: Acetamides; Animals; Anti-Bacterial Agents; Area Under Curve; Bacterial Infections; Behavior, Animal; Calibration; Cation Transport Proteins; DNA; Dogs; Ether-A-Go-Go Potassium Channels; Female; Heterocyclic Compounds; Linezolid; Male; Mice; Mice, Inbred ICR; Muscle, Skeletal; Mutagens; Neutropenia; Oxazolidinones; Peritonitis; Pneumonia, Pneumococcal; Potassium Channels; Potassium Channels, Voltage-Gated; Protein Binding; Rats; Rats, Sprague-Dawley; Tissue Distribution; Vancomycin | 2003 |
Adult staphylococcus scalded skin syndrome in a peritoneal dialysis patient.
Topics: Anti-Bacterial Agents; Dopamine; Fluid Therapy; Humans; Kidney Failure, Chronic; Male; Middle Aged; Peritoneal Dialysis; Peritonitis; Shock; Staphylococcal Scalded Skin Syndrome; Vancomycin | 2003 |
Increased killing of staphylococci and streptococci by daptomycin compared with cefazolin and vancomycin in an in vitro peritoneal dialysate model.
Topics: Anti-Bacterial Agents; Cefazolin; Cephalosporins; Colony Count, Microbial; Daptomycin; Dialysis Solutions; Hydrogen-Ion Concentration; Methicillin Resistance; Peritoneal Dialysis; Peritonitis; Protein Binding; Staphylococcus; Streptococcus; Vancomycin | 2003 |
DNA binding ligands with improved in vitro and in vivo potency against drug-resistant Staphylococcus aureus.
Topics: Animals; Distamycins; DNA; Dose-Response Relationship, Drug; Drug Resistance; Kinetics; Ligands; Methicillin; Mice; Peritonitis; Staphylococcal Infections; Staphylococcus aureus; Structure-Activity Relationship; Survival Rate; Vancomycin | 2004 |
Chryseobacterium meningosepticum infections in a dialysis unit.
Topics: Chryseobacterium; Ciprofloxacin; Cross Infection; Equipment Contamination; Flavobacteriaceae Infections; Hemodialysis Units, Hospital; Hospitals, General; Hospitals, Teaching; Humans; Peritoneal Dialysis; Peritonitis; Retrospective Studies; Sepsis; Sri Lanka; Vancomycin | 2004 |
Mycobacterium simiae: a previously undescribed pathogen in peritoneal dialysis peritonitis.
Topics: Adult; AIDS-Related Opportunistic Infections; Amikacin; Amoxicillin; Antiretroviral Therapy, Highly Active; Candidiasis, Oral; Ciprofloxacin; Clarithromycin; Drug Therapy, Combination; Equipment Contamination; Gentamicins; Humans; Immunocompromised Host; Kidney Failure, Chronic; Male; Mycobacterium; Mycobacterium Infections; Peritoneal Dialysis, Continuous Ambulatory; Peritonitis; Pneumonia, Pneumocystis; Renal Dialysis; Rifabutin; Vancomycin | 2005 |
Three-year analysis of microbial aetiology and antimicrobial susceptibilities of PD peritonitis.
Topics: Aged; Aminoglycosides; Anti-Bacterial Agents; Cephalosporins; Cephalothin; Dialysis Solutions; Female; Glucans; Glucose; Humans; Icodextrin; Male; Microbial Sensitivity Tests; Middle Aged; Peritoneal Dialysis; Peritonitis; Retrospective Studies; Tobramycin; Vancomycin | 2006 |
Ciprofloxacin treatment of bacterial peritonitis associated with chronic ambulatory peritoneal dialysis caused by Neisseria cinerea.
Topics: Adult; Anti-Bacterial Agents; Ciprofloxacin; Gentamicins; Humans; Kidney Failure, Chronic; Male; Neisseria cinerea; Neisseriaceae Infections; Peritoneal Dialysis, Continuous Ambulatory; Peritonitis; Vancomycin | 2006 |
Efficacy and safety of meropenem plus tobramycin followed by meropenem plus vancomycin for treating peritonitis in patients on continuous ambulatory peritoneal dialysis.
Topics: Anti-Bacterial Agents; Drug Administration Schedule; Drug Therapy, Combination; Female; Humans; Male; Meropenem; Middle Aged; Peritoneal Dialysis, Continuous Ambulatory; Peritonitis; Thienamycins; Tobramycin; Treatment Outcome; Vancomycin | 2006 |
Single UK centre experience on the treatment of PD peritonitis--antibiotic levels and outcomes.
Topics: Anti-Bacterial Agents; beta-Lactam Resistance; Ceftazidime; Drug Administration Schedule; Drug Therapy, Combination; Female; Gentamicins; Humans; Male; Middle Aged; Peritoneal Dialysis; Peritonitis; Treatment Outcome; United Kingdom; Vancomycin | 2007 |
Inguinal site infection as a rare cause of secondary peritonitis: report of a case.
Topics: Adult; Anti-Bacterial Agents; Cutaneous Fistula; Fistula; Humans; Inguinal Canal; Injections, Intravenous; Male; Methicillin Resistance; Peritoneal Diseases; Peritonitis; Pneumoperitoneum; Radiography; Staphylococcal Infections; Substance Abuse, Intravenous; Vancomycin | 2007 |
Rapid detection of causative pathogen of peritonitis using in-situ hybridization in a patient with continuous ambulatory peritoneal dialysis.
Topics: Anti-Bacterial Agents; Female; Humans; In Situ Hybridization; Middle Aged; Peritoneal Dialysis, Continuous Ambulatory; Peritonitis; Staphylococcal Infections; Staphylococcus epidermidis; Vancomycin | 2007 |
Spontaneous bacterial peritonitis in terminal renal failure.
Topics: Adult; Anti-Bacterial Agents; Ascites; Cefotaxime; Drug Therapy, Combination; Humans; Imipenem; Kidney Failure, Chronic; Male; Peritonitis; Renal Dialysis; Staphylococcal Infections; Staphylococcus epidermidis; Vancomycin | 2007 |
Coagulase negative staphylococcal peritonitis in peritoneal dialysis patients: review of 232 consecutive cases.
Topics: Adult; Aged; Anti-Bacterial Agents; Cefazolin; Female; Humans; Kidney Failure, Chronic; Male; Methicillin Resistance; Middle Aged; Peritoneal Dialysis; Peritonitis; Risk Factors; Secondary Prevention; Staphylococcal Infections; Treatment Outcome; Vancomycin | 2008 |
Once-daily antibiotic treatment of CAPD peritonitis.
Topics: Drug Therapy, Combination; Gentamicins; Humans; Peritoneal Dialysis; Peritoneal Dialysis, Continuous Ambulatory; Peritonitis; Vancomycin | 1984 |
Species identification and antibiotic sensitivity of coagulase-negative staphylococci from CAPD peritonitis.
Topics: Anti-Bacterial Agents; Bacteriophage Typing; beta-Lactamases; Coagulase; Drug Resistance, Microbial; Humans; Microbial Sensitivity Tests; Peritoneal Dialysis; Peritoneal Dialysis, Continuous Ambulatory; Peritonitis; Staphylococcal Infections; Staphylococcus; Vancomycin | 1984 |
[A case of primary peritonitis and bilateral pneumonia caused by staphylococcal emboli in drug dependence].
Topics: Adolescent; Female; Heroin Dependence; Humans; Injections, Intravenous; Peritonitis; Pneumonia, Staphylococcal; Rifampin; Staphylococcal Infections; Vancomycin | 1984 |
Vancomycin kinetics during continuous ambulatory peritoneal dialysis.
Topics: Adult; Humans; Injections, Intraperitoneal; Injections, Intravenous; Kinetics; Middle Aged; Peritoneal Dialysis; Peritoneal Dialysis, Continuous Ambulatory; Peritonitis; Vancomycin | 1983 |
Group JK corynebacterium peritonitis in a patient undergoing continuous ambulatory peritoneal dialysis.
Topics: Aged; Corynebacterium Infections; Humans; Peritoneal Dialysis; Peritoneal Dialysis, Continuous Ambulatory; Peritonitis; Vancomycin | 1983 |
Intraleukocytic sequestration as a cause of persistent Staphylococcus aureus peritonitis in continuous ambulatory peritoneal dialysis.
Topics: Adult; Blood Bactericidal Activity; Cephalothin; Child; Female; Humans; Lysostaphin; Male; Middle Aged; Neutrophils; Peritoneal Cavity; Peritoneal Dialysis; Peritoneal Dialysis, Continuous Ambulatory; Peritonitis; Staphylococcal Infections; Staphylococcus aureus; Tobramycin; Vancomycin | 1984 |
Treatment of peritonitis complicating continuous ambulatory peritoneal dialysis.
Topics: Aminoglycosides; Anti-Bacterial Agents; Cephalosporins; Humans; Peritoneal Dialysis; Peritoneal Dialysis, Continuous Ambulatory; Peritonitis; Staphylococcal Infections; Vancomycin | 1984 |
Pseudomonas peritonitis and continuous ambulatory peritoneal dialysis.
Topics: Adult; Ascitic Fluid; Female; Humans; Male; Middle Aged; Peritoneal Dialysis; Peritoneal Dialysis, Continuous Ambulatory; Peritonitis; Pseudomonas aeruginosa; Pseudomonas Infections; Vancomycin | 1982 |
Vancomycin pharmacokinetics in patients with peritonitis on peritoneal dialysis.
Topics: Aged; Ascitic Fluid; Humans; Kinetics; Middle Aged; Peritoneal Dialysis; Peritonitis; Time Factors; Vancomycin | 1983 |
Efficacy of intravenous vancomycin in the treatment of gram-positive peritonitis in long-term peritoneal dialysis.
Topics: Bacteria; Bacterial Infections; Humans; Peritoneal Dialysis; Peritoneal Dialysis, Continuous Ambulatory; Peritonitis; Vancomycin | 1983 |
[Peritonitis among patients treated with continuous ambulatory peritoneal dialysis].
Topics: Adolescent; Adult; Aged; Female; Gentamicins; Humans; Male; Middle Aged; Peritoneal Dialysis, Continuous Ambulatory; Peritonitis; Vancomycin | 1995 |
Trough serum vancomycin levels predict the relapse of gram-positive peritonitis in peritoneal dialysis patients.
Topics: Gram-Positive Bacterial Infections; Humans; Middle Aged; Peritoneal Dialysis; Peritoneal Dialysis, Continuous Ambulatory; Peritonitis; Recurrence; Vancomycin | 1995 |
The emergence of vancomycin resistance in renal dialysis.
Topics: Aged; Coagulase; Drug Resistance, Microbial; Enterococcus; Female; Gram-Positive Bacterial Infections; Humans; Lactobacillus; Male; Microbial Sensitivity Tests; Middle Aged; Peritoneal Dialysis, Continuous Ambulatory; Peritonitis; Staphylococcus; Vancomycin | 1993 |
Listeria monocytogenes CAPD peritonitis: failure of vancomycin therapy.
Topics: Ampicillin; Gentamicins; Humans; Listeriosis; Male; Microbial Sensitivity Tests; Middle Aged; Peritoneal Dialysis, Continuous Ambulatory; Peritonitis; Vancomycin | 1994 |
Pharmacokinetics and pharmacodynamics of antistaphylococcal antibiotics in continuous ambulatory peritoneal dialysis patients.
Topics: Anti-Bacterial Agents; Humans; Penicillins; Peritoneal Dialysis, Continuous Ambulatory; Peritonitis; Rifampin; Staphylococcal Infections; Staphylococcus; Vancomycin | 1993 |
Single-dose intraperitoneal vancomycin and oral ciprofloxacin for the treatment of peritonitis in CAPD patients: preliminary report.
Topics: Administration, Oral; Ciprofloxacin; Drug Therapy, Combination; Humans; Microbial Sensitivity Tests; Peritoneal Dialysis, Continuous Ambulatory; Peritonitis; Vancomycin | 1993 |
Allergic cross-reactivity to teicoplanin and vancomycin.
Topics: Aged; Cross Reactions; Drug Hypersensitivity; Female; Humans; Peritonitis; Teicoplanin; Vancomycin | 1993 |
[Peritonitis in continuous ambulatory peritoneal dialysis. An evaluation of the empiric initial antibiotic treatment].
Topics: Adolescent; Adult; Aged; Anti-Bacterial Agents; Drug Resistance, Microbial; Drug Therapy, Combination; Evaluation Studies as Topic; Female; Gentamicins; Humans; Male; Middle Aged; Peritoneal Dialysis, Continuous Ambulatory; Peritonitis; Retrospective Studies; Vancomycin | 1996 |
[Peritonitis in continuous ambulatory peritoneal dialysis. Culture of peritoneal dialysate fluid].
Topics: Adolescent; Adult; Aged; Anti-Bacterial Agents; Bacteriological Techniques; Drug Therapy, Combination; Female; Gentamicins; Humans; Male; Middle Aged; Peritoneal Dialysis, Continuous Ambulatory; Peritonitis; Vancomycin | 1996 |
Usefulness of the endotoxin test for assessing CAPD peritonitis by gram-negative organisms.
Topics: Adult; Aged; Anti-Bacterial Agents; Endotoxins; Female; Gram-Negative Bacterial Infections; Humans; Kidney Failure, Chronic; Limulus Test; Male; Middle Aged; Peritoneal Dialysis, Continuous Ambulatory; Peritonitis; Vancomycin | 1996 |
Nine episodes of CPD-associated peritonitis with vancomycin resistant enterococci.
Topics: Adult; Aged; Drug Resistance, Microbial; Enterococcus; Female; Gram-Positive Bacterial Infections; Humans; Male; Middle Aged; Peritoneal Dialysis; Peritonitis; Retrospective Studies; Vancomycin | 1996 |
[Treatment of peritonitis in patients on chronic peritoneal dialysis with a single dose of vancomycin].
Topics: Aged; Anti-Bacterial Agents; Drug Administration Schedule; Female; Humans; Male; Middle Aged; Peritoneal Dialysis; Peritonitis; Vancomycin | 1996 |
Leuconostoc bacteremia after liver transplantation: another cause of vancomycin resistant gram-positive infection.
Topics: Adult; Anti-Bacterial Agents; Bacteremia; Catheterization, Central Venous; Clindamycin; Debridement; Drug Resistance, Microbial; Fatal Outcome; Fever; Follow-Up Studies; Gentamicins; Gram-Positive Bacterial Infections; Humans; Leuconostoc; Liver Transplantation; Male; Peritonitis; Streptococcal Infections; Vancomycin | 1997 |
Staphylococcus aureus with reduced susceptibility to vancomycin--United States, 1997.
Topics: Anti-Bacterial Agents; Drug Resistance, Microbial; Humans; Microbial Sensitivity Tests; Peritonitis; Staphylococcal Infections; Staphylococcus aureus; United States; Vancomycin | 1997 |
From the Centers for Disease Control and Prevention. Staphylococcus aureus with reduced susceptibility to vancomycin--United States, 1997.
Topics: Anti-Bacterial Agents; Drug Resistance, Microbial; Humans; Microbial Sensitivity Tests; Peritonitis; Staphylococcal Infections; Staphylococcus aureus; United States; Vancomycin | 1997 |
Activities of vancomycin and teicoplanin against penicillin-resistant pneumococci in vitro and in vivo and correlation to pharmacokinetic parameters in the mouse peritonitis model.
Topics: Animals; Anti-Bacterial Agents; Blood Proteins; Humans; Mice; Microbial Sensitivity Tests; Penicillin Resistance; Peritonitis; Pneumococcal Infections; Streptococcus pneumoniae; Teicoplanin; Vancomycin | 1997 |
Recurrent peritonitis in a patient on dialysis and prophylactic vancomycin.
Topics: Adult; Anti-Bacterial Agents; Female; Humans; Microbial Sensitivity Tests; Peritoneal Dialysis; Peritonitis; Recurrence; Staphylococcal Infections; Staphylococcus epidermidis; Vancomycin | 1998 |
Vancomycin administration in continuous ambulatory peritoneal dialysis: the risk of ototoxicity.
Topics: Adult; Aged; Anti-Bacterial Agents; Audiometry, Pure-Tone; Auditory Threshold; Caloric Tests; Dose-Response Relationship, Drug; Drug Administration Schedule; Female; Hearing Loss, Sensorineural; Humans; Male; Metabolic Clearance Rate; Middle Aged; Peritoneal Dialysis, Continuous Ambulatory; Peritonitis; Recurrence; Vancomycin | 1998 |
Peritonitis associated with vancomycin-resistant Lactobacillus rhamnosus in a continuous ambulatory peritoneal dialysis patient: organism identification, antibiotic therapy, and case report.
Topics: Anti-Bacterial Agents; Drug Resistance, Microbial; Gram-Positive Bacterial Infections; Humans; Lactobacillus; Male; Microbial Sensitivity Tests; Middle Aged; Peritoneal Dialysis, Continuous Ambulatory; Peritonitis; Teicoplanin; Vancomycin | 1998 |
Neisseria meningitidis serogroup B peritonitis associated with continuous ambulatory peritoneal dialysis.
Topics: Adult; Anti-Bacterial Agents; Female; Humans; Kidney Failure, Chronic; Meningococcal Infections; Microbial Sensitivity Tests; Neisseria meningitidis; Peritoneal Dialysis, Continuous Ambulatory; Peritonitis; Serotyping; Vancomycin | 1998 |
Vancomycin therapy for treatment of peritonitis in outpatients on peritoneal dialysis.
Topics: Adult; Aged; Ambulatory Care; Anti-Bacterial Agents; Female; Humans; Injections, Intraperitoneal; Male; Middle Aged; Peritoneal Dialysis, Continuous Ambulatory; Peritonitis; Vancomycin | 1998 |
Heterogeneously vancomycin-resistant Staphylococcus epidermidis strain causing recurrent peritonitis in a dialysis patient during vancomycin therapy.
Topics: Adult; Anti-Bacterial Agents; Antibiotic Prophylaxis; Female; Humans; Methicillin Resistance; Microbial Sensitivity Tests; Peritoneal Dialysis; Peritonitis; Recurrence; Staphylococcal Infections; Staphylococcus epidermidis; Vancomycin | 1999 |
Emergence of vancomycin resistance in Staphylococcus aureus. Glycopeptide-Intermediate Staphylococcus aureus Working Group.
Topics: Aged; Anti-Bacterial Agents; Bacteremia; Contact Tracing; Diabetes Complications; Drug Resistance, Microbial; Electrophoresis, Gel, Pulsed-Field; Fatal Outcome; Humans; Infection Control; Kidney Failure, Chronic; Male; Methicillin Resistance; Michigan; Microbial Sensitivity Tests; Middle Aged; New Jersey; Peritonitis; Staphylococcal Infections; Staphylococcus aureus; Vancomycin | 1999 |
Vancomycin-dependent enterococci in a uraemic patient with sclerosing peritonitis.
Topics: Adult; Anti-Bacterial Agents; Drug Resistance, Microbial; Enterococcus faecalis; Female; Humans; Peritoneal Dialysis, Continuous Ambulatory; Peritonitis; Sclerosis; Uremia; Vancomycin | 1999 |
Treatment of peritonitis in pediatric continuous peritoneal dialysis.
Topics: Anti-Bacterial Agents; Bacterial Infections; Child; Humans; Peritoneal Dialysis; Peritonitis; Recurrence; Staphylococcal Infections; Teicoplanin; Vancomycin | 1999 |
Pharmacodynamics of glycopeptides in the mouse peritonitis model of Streptococcus pneumoniae or Staphylococcus aureus infection.
Topics: Animals; Anti-Bacterial Agents; Disease Models, Animal; Female; Metabolic Clearance Rate; Mice; Microbial Sensitivity Tests; Peritonitis; Pneumococcal Infections; Staphylococcal Infections; Staphylococcus aureus; Streptococcus pneumoniae; Teicoplanin; Vancomycin | 2000 |
Treatment of peritoneal dialysis related peritonitis--an Australian and New Zealand perspective.
Topics: Algorithms; Anti-Bacterial Agents; Australia; Catheterization; Cephalosporins; Humans; New Zealand; Peritoneal Dialysis; Peritonitis; Pseudomonas Infections; Vancomycin | 1999 |
Successful use of recombinant tissue plasminogen activator in a patient with relapsing peritonitis.
Topics: Adult; Cefepime; Cephalosporins; Ciprofloxacin; Drug Therapy, Combination; Gentamicins; Humans; Injections, Intraperitoneal; Male; Peritoneal Dialysis, Continuous Ambulatory; Peritonitis; Recombinant Proteins; Recurrence; Remission Induction; Tissue Plasminogen Activator; Vancomycin | 2001 |
Clinical course of peritonitis due to Pseudomonas species complicating peritoneal dialysis: a review of 104 cases.
Topics: Adult; Aged; Anti-Bacterial Agents; Cephalosporins; Equipment Contamination; Female; Gentamicins; Humans; Incidence; Kidney Failure, Chronic; Male; Middle Aged; Netilmicin; Peritoneal Dialysis, Continuous Ambulatory; Peritonitis; Pseudomonas Infections; Retrospective Studies; Secondary Prevention; Vancomycin | 2001 |
Staphylococcus epidermidis with intermediate resistance to vancomycin: elusive phenotype or laboratory artifact?
Topics: Anti-Bacterial Agents; Artifacts; Catheters, Indwelling; Drug Resistance, Microbial; Female; Humans; Laboratories; Middle Aged; Peritoneal Dialysis, Continuous Ambulatory; Peritonitis; Phenotype; Staphylococcal Infections; Staphylococcus epidermidis; Vancomycin; Vancomycin Resistance | 2001 |
A case of Campylobacter jejuni peritonitis in a patient undergoing peritoneal dialysis.
Topics: Adult; Anti-Bacterial Agents; Campylobacter Infections; Campylobacter jejuni; Female; Gentamicins; Heparin; Humans; Peritoneal Dialysis, Continuous Ambulatory; Peritonitis; Vancomycin | 2001 |
Spontaneous bacterial peritonitis and bacteremia due to Leuconostoc species in a patient with end-stage liver disease: a case report.
Topics: Anti-Bacterial Agents; Ascitic Fluid; Bacteremia; Diabetes Mellitus, Type 2; Fatal Outcome; Humans; Leuconostoc; Liver Cirrhosis; Male; Middle Aged; Peritonitis; Vancomycin | 2001 |
Unusual presentation of psoas abscess in a child.
Topics: Diagnosis, Differential; Drainage; Female; Humans; Infant; Peritonitis; Psoas Abscess; Rupture, Spontaneous; Treatment Outcome; Vancomycin | 2001 |
Hemodiafiltration for vancomycin overdose in a patient with end-stage renal failure.
Topics: Adolescent; Anti-Bacterial Agents; Biocompatible Materials; Drug Overdose; Female; Hemodiafiltration; Humans; Kidney Failure, Chronic; Medication Errors; Membranes, Artificial; Peritonitis; Polymers; Sulfones; Vancomycin | 2001 |
Peritoneal clearance and total body elimination of vancomycin during chronic intermittent peritoneal dialysis.
Topics: Adult; Ascitic Fluid; Biological Availability; Female; Humans; Male; Peritoneal Dialysis; Peritonitis; Staphylococcal Infections; Vancomycin | 1979 |
Peritoneal transport of vancomycin during peritoneal dialysis.
Topics: Adolescent; Adult; Half-Life; Humans; Injections, Intravenous; Middle Aged; Peritoneal Dialysis; Peritonitis; Staphylococcal Infections; Uremia; Vancomycin | 1979 |
Antibiotic-associated colitis: report of a case.
Topics: Amikacin; Enterobacteriaceae Infections; Enterocolitis, Pseudomembranous; Humans; Injections, Intraperitoneal; Kanamycin; Male; Middle Aged; Peritonitis; Vancomycin | 1978 |
Hearing thresholds in CAPD patients.
Topics: Adult; Aged; Auditory Threshold; Female; Hearing Loss, High-Frequency; Humans; Kidney Failure, Chronic; Male; Middle Aged; Peritoneal Dialysis, Continuous Ambulatory; Peritonitis; Vancomycin | 1992 |
Treatment of relapsing peritonitis in pediatric patients on peritoneal dialysis.
Topics: Adolescent; Cefotaxime; Child; Child, Preschool; Drug Therapy, Combination; Fosfomycin; Humans; Infant; Peritoneal Dialysis; Peritoneal Dialysis, Continuous Ambulatory; Peritonitis; Prospective Studies; Recurrence; Thrombolytic Therapy; Urokinase-Type Plasminogen Activator; Vancomycin | 1992 |
CAPD peritonitis caused by Lactobacillus rhamnosus.
Topics: Drug Resistance, Microbial; Gram-Positive Bacterial Infections; Humans; Lactobacillus; Male; Middle Aged; Peritoneal Dialysis, Continuous Ambulatory; Peritonitis; Vancomycin | 1992 |
Enterocolitis due to methicillin-resistant Staphylococcus aureus--report of two cases.
Topics: Enterocolitis; Gastrectomy; Humans; Male; Methicillin Resistance; Middle Aged; Peritonitis; Staphylococcus aureus; Stomach Neoplasms; Surgical Wound Infection; Vancomycin | 1992 |
Chemical peritonitis following the intraperitoneal administration of vancomycin.
Topics: Adverse Drug Reaction Reporting Systems; Catheters, Indwelling; Female; Humans; Infusions, Parenteral; Male; Middle Aged; Peritoneal Dialysis, Continuous Ambulatory; Peritonitis; Skin Diseases, Infectious; United States; United States Food and Drug Administration; Vancomycin | 1992 |
Netilmycin and vancomycin in the treatment of peritonitis in CAPD patients.
Topics: Adult; Aged; Cefuroxime; Drug Therapy, Combination; Female; Humans; Male; Middle Aged; Netilmicin; Peritoneal Dialysis, Continuous Ambulatory; Peritonitis; Pilot Projects; Random Allocation; Staphylococcal Infections; Vancomycin | 1992 |
Prediction of serum vancomycin concentrations following intraperitoneal loading doses in continuous ambulatory peritoneal dialysis patients with peritonitis.
Topics: Adolescent; Adult; Aged; Algorithms; Dialysis Solutions; Female; Humans; Male; Middle Aged; Peritoneal Dialysis, Continuous Ambulatory; Peritonitis; Vancomycin | 1992 |
Peritonitis due to vancomycin-resistant Staphylococcus epidermidis.
Topics: Drug Resistance, Microbial; Humans; Male; Middle Aged; Peritoneal Dialysis, Continuous Ambulatory; Peritonitis; Staphylococcal Infections; Staphylococcus epidermidis; Vancomycin | 1991 |
Chemical peritonitis associated with intraperitoneal vancomycin.
Topics: Adult; Ascitic Fluid; Female; Humans; Injections, Intraperitoneal; Peritonitis; Vancomycin | 1991 |
Long-term, intraperitoneal vancomycin in the prevention of recurrent peritonitis during CAPD: preliminary results.
Topics: Adult; Aged; Aged, 80 and over; Humans; Infusions, Parenteral; Peritoneal Dialysis, Continuous Ambulatory; Peritonitis; Recurrence; Time Factors; Vancomycin | 1991 |
Vancomycin therapy failure in Listeria monocytogenes peritonitis in a patient on continuous ambulatory peritoneal dialysis.
Topics: Humans; Listeriosis; Male; Middle Aged; Peritoneal Dialysis, Continuous Ambulatory; Peritonitis; Vancomycin | 1991 |
Efficacy of vancomycin plus tobramycin as antiperitonitis regimen for patients on CAPD.
Topics: Drug Therapy, Combination; Female; Humans; Male; Middle Aged; Peritoneal Dialysis, Continuous Ambulatory; Peritonitis; Staphylococcal Infections; Staphylococcus epidermidis; Tobramycin; Vancomycin | 1990 |
Chemical peritonitis secondary to intraperitoneal vancomycin.
Topics: Adult; Chromatography, High Pressure Liquid; Drug Contamination; Female; Humans; Middle Aged; Peritoneal Dialysis, Continuous Ambulatory; Peritonitis; Therapeutic Equivalency; Vancomycin | 1991 |
Ototoxicity monitoring with ultra-high frequency audiometry in peritoneal dialysis patients treated with vancomycin or gentamicin.
Topics: Audiometry; Female; Gentamicins; Hearing Loss, High-Frequency; Humans; Middle Aged; Monitoring, Physiologic; Peritoneal Dialysis, Continuous Ambulatory; Peritonitis; Vancomycin | 1991 |
Intraperitoneal vancomycin administration.
Topics: Drug Administration Schedule; Humans; Infusions, Parenteral; Injections, Intraperitoneal; Peritoneal Dialysis; Peritonitis; Vancomycin | 1991 |
Does intraperitoneal vancomycin cause chemical peritonitis?
Topics: Humans; Injections, Intraperitoneal; Peritonitis; Vancomycin | 1991 |
Intraperitoneal secretion of interleukin-6 during continuous ambulatory peritoneal dialysis.
Topics: Ascitic Fluid; Cefazolin; Female; Humans; Injections, Intraperitoneal; Interleukin-6; Male; Peritoneal Dialysis, Continuous Ambulatory; Peritonitis; Staphylococcal Infections; Vancomycin | 1990 |
Bacterial aggregation in relation to peritoneal dialysis.
Topics: Bacterial Adhesion; Dialysis Solutions; Humans; Microscopy, Electron; Peritoneal Dialysis, Continuous Ambulatory; Peritonitis; Staphylococcal Infections; Staphylococcus aureus; Staphylococcus epidermidis; Vancomycin | 1990 |
Peritonitis following colonoscopy in a peritoneal dialysis patient.
Topics: Aged; Bacteria, Anaerobic; Bacterial Infections; Colonic Polyps; Colonoscopy; Female; Gentamicins; Humans; Peritoneal Dialysis, Continuous Ambulatory; Peritonitis; Premedication; Vancomycin | 1990 |
More experience with Vancoled induced chemical peritonitis.
Topics: Adult; Aged; Bacterial Infections; Catheters, Indwelling; Drug Contamination; Female; Humans; Male; Middle Aged; Peritoneal Dialysis, Continuous Ambulatory; Peritonitis; Vancomycin | 1990 |
Vancomycin absorption from the peritoneal cavity during dialysis-related peritonitis.
Topics: Absorption; Acute Disease; Adult; Aged; Humans; Middle Aged; Peritoneal Cavity; Peritoneal Dialysis, Continuous Ambulatory; Peritonitis; Vancomycin | 1990 |
Treatment of severe hypophosphatemia with intraperitoneal phosphate.
Topics: Chronic Disease; Female; Humans; Injections, Intraperitoneal; Middle Aged; Peritoneal Dialysis, Continuous Ambulatory; Peritonitis; Phosphates; Vancomycin | 1990 |
CAPD peritonitis caused by vancomycin-resistant lactobacilli.
Topics: Drug Resistance, Microbial; Enterobacter; Enterobacteriaceae Infections; Humans; Lactobacillus; Male; Middle Aged; Peritoneal Dialysis, Continuous Ambulatory; Peritonitis; Rifampin; Vancomycin | 1990 |
Red-neck syndrome associated with intraperitoneal vancomycin.
Topics: Adult; Female; Humans; Infusions, Parenteral; Peritonitis; Pruritus; Vancomycin | 1990 |
Pharmacokinetics of once daily intra-peritoneal aztreonam and vancomycin in the treatment of CAPD peritonitis.
Topics: Aztreonam; Humans; Injections, Intraperitoneal; Kidney Failure, Chronic; Middle Aged; Peritoneal Dialysis, Continuous Ambulatory; Peritonitis; Vancomycin | 1990 |
Continuous ambulatory peritoneal dialysis (CAPD) peritonitis: the effect of antibiotic on the adherence of coagulase-negative staphylococci to silicone rubber catheter material.
Topics: Bacterial Adhesion; Catheters, Indwelling; Cefuroxime; Ciprofloxacin; Humans; Peritoneal Dialysis, Continuous Ambulatory; Peritonitis; Silicone Elastomers; Staphylococcus epidermidis; Vancomycin | 1989 |
Intraperitoneal Vancoled does not cause chemical peritonitis.
Topics: Humans; Infusions, Parenteral; Peritoneal Dialysis, Continuous Ambulatory; Peritonitis; Vancomycin | 1989 |
Urokinase: a treatment for relapsing peritonitis due to coagulase-negative staphylococci.
Topics: Bacterial Typing Techniques; Drug Therapy, Combination; Follow-Up Studies; Humans; Length of Stay; Peritoneal Dialysis, Continuous Ambulatory; Peritonitis; Recurrence; Retrospective Studies; Staphylococcal Infections; Staphylococcus; Urokinase-Type Plasminogen Activator; Vancomycin | 1989 |
The prevention of infection with Staphylococcus aureus in continuous ambulatory peritoneal dialysis.
Topics: Anti-Infective Agents, Local; Asepsis; Catheters, Indwelling; Chlorhexidine; Cross Infection; Female; Floxacillin; Humans; Male; Occlusive Dressings; Peritoneal Dialysis, Continuous Ambulatory; Peritonitis; Staphylococcal Infections; Vancomycin; Wound Infection | 1989 |
Intraperitoneal Vancoled does not cause chemical peritonitis.
Topics: Adult; Catheters, Indwelling; Cell Count; Dialysis Solutions; Humans; Infections; Infusions, Parenteral; Peritoneal Dialysis, Continuous Ambulatory; Peritonitis; Prospective Studies; Vancomycin | 1989 |
Peritonitis in continuous ambulatory peritoneal dialysis patients in southern Israel.
Topics: Adult; Aged; Aminoglycosides; Anti-Bacterial Agents; Bacteria; Cefazolin; Female; Follow-Up Studies; Humans; Israel; Male; Middle Aged; Peritoneal Dialysis, Continuous Ambulatory; Peritonitis; Recurrence; Risk Factors; Vancomycin | 1989 |
Vancomycin and ceftazidime in the treatment of CAPD peritonitis.
Topics: Adolescent; Adult; Aged; Ceftazidime; Drug Therapy, Combination; Female; Humans; Male; Middle Aged; Peritoneal Dialysis, Continuous Ambulatory; Peritonitis; Vancomycin | 1989 |
Corynebacterium equi peritonitis in a patient receiving peritoneal dialysis.
Topics: Aged; Corynebacterium; Corynebacterium Infections; Humans; Male; Peritoneal Dialysis, Continuous Ambulatory; Peritonitis; Vancomycin | 1989 |
Rhodococcus peritonitis in a patient treated with peritoneal dialysis.
Topics: Actinomycetales Infections; Cefazolin; Humans; Male; Middle Aged; Peritoneal Dialysis; Peritonitis; Recurrence; Rhodococcus; Vancomycin | 1989 |
Thrombocytopenia due to vancomycin.
Topics: Female; Humans; Middle Aged; Peritoneal Dialysis, Continuous Ambulatory; Peritonitis; Thrombocytopenia; Vancomycin | 1985 |
Vancomycin, red neck syndrome, and fits.
Topics: Adolescent; Anaphylaxis; Female; Humans; Infusions, Parenteral; Kidney Failure, Chronic; Peritonitis; Seizures; Vancomycin | 1985 |
Allergy, red man syndrome, and vancomycin.
Topics: Adult; Erythema; Female; Humans; Peritonitis; Vancomycin | 1985 |
Lack of chemical peritonitis after intraperitoneal use of two brands of vancomycin hydrochloride.
Topics: Humans; Instillation, Drug; Peritonitis; Vancomycin | 1989 |
Vancomycin-induced vasculitis.
Topics: Drug Eruptions; Female; Humans; Middle Aged; Peritonitis; Staphylococcal Infections; Vancomycin; Vasculitis | 1986 |
Activity of teicoplanin against coagulase-negative staphylococci isolated from patients undergoing continuous peritoneal dialysis.
Topics: Drug Resistance, Microbial; Glycopeptides; Humans; Microbial Sensitivity Tests; Peritoneal Dialysis, Continuous Ambulatory; Peritonitis; Staphylococcal Infections; Staphylococcus; Teicoplanin; Vancomycin | 1986 |
In vitro antistaphylococcal activity of teicoplanin and ciprofloxacin in peritoneal dialysis effluent.
Topics: Anti-Bacterial Agents; Ascitic Fluid; Cefazolin; Ciprofloxacin; Glycopeptides; Humans; Oxacillin; Peritoneal Dialysis, Continuous Ambulatory; Peritonitis; Staphylococcal Infections; Staphylococcus; Staphylococcus epidermidis; Teicoplanin; Vancomycin | 1986 |
Absorption of intraperitoneal antibiotics.
Topics: Absorption; Anti-Bacterial Agents; Cefamandole; Humans; Infusions, Parenteral; Kidney Failure, Chronic; Moxalactam; Peritoneal Dialysis, Continuous Ambulatory; Peritonitis; Radioimmunoassay; Tobramycin; Vancomycin | 1988 |
[Treatment of peritonitis during continuous ambulatory peritoneal dialysis (CAPD) with co-trimoxazole, cefazolin or vancomycin].
Topics: Anti-Bacterial Agents; Anti-Infective Agents; Aspergillus; Bacteria; Candida; Cefazolin; Drug Combinations; Drug Resistance, Microbial; Humans; Peritoneal Dialysis, Continuous Ambulatory; Peritonitis; Sulfamethoxazole; Trimethoprim; Trimethoprim, Sulfamethoxazole Drug Combination; Vancomycin | 1987 |
Pharmacokinetics of single dose intravenous vancomycin in CAPD peritonitis.
Topics: Aged; Female; Half-Life; Humans; Infusions, Intravenous; Kidney Failure, Chronic; Kinetics; Male; Middle Aged; Peritoneal Dialysis, Continuous Ambulatory; Peritonitis; Vancomycin | 1987 |
Treatment of gram-positive peritonitis with two intraperitoneal doses of vancomycin in continuous ambulatory peritoneal dialysis patients.
Topics: Bacterial Infections; Drug Administration Schedule; Gram-Positive Bacteria; Humans; Peritoneal Dialysis, Continuous Ambulatory; Peritonitis; Vancomycin | 1987 |
Effect of vancomycin hydrochloride on Staphylococcus epidermidis biofilm associated with silicone elastomer.
Topics: Humans; Microbial Sensitivity Tests; Microscopy, Electron, Scanning; Peritoneal Dialysis, Continuous Ambulatory; Peritonitis; Silicone Elastomers; Staphylococcus epidermidis; Vancomycin | 1987 |
Intravenous or intraperitoneal vancomycin for the treatment of continuous ambulatory peritoneal dialysis associated gram-positive peritonitis?
Topics: Bacterial Infections; Drug Evaluation; Female; Gram-Positive Bacteria; Humans; Infusions, Intravenous; Injections, Intraperitoneal; Male; Peritoneal Dialysis, Continuous Ambulatory; Peritonitis; Time Factors; Vancomycin | 1987 |
Once weekly intraperitoneal therapy for gram-positive peritonitis.
Topics: Adult; Drug Administration Schedule; Female; Humans; Infusions, Parenteral; Male; Middle Aged; Peritoneal Dialysis, Continuous Ambulatory; Peritonitis; Vancomycin | 1987 |
Vancomycin pharmacokinetics in continuous ambulatory peritoneal dialysis patients with peritonitis.
Topics: Adult; Female; Humans; Injections, Intravenous; Kidney Failure, Chronic; Kinetics; Male; Metabolic Clearance Rate; Middle Aged; Peritoneal Dialysis, Continuous Ambulatory; Peritonitis; Vancomycin | 1986 |
Emergence of vancomycin resistance in coagulase-negative staphylococci.
Topics: Adult; Coagulase; Drug Resistance, Microbial; Humans; Male; Peritonitis; Staphylococcus; Vancomycin | 1987 |
Intraperitoneal vancomycin and ceftazidime in the treatment of CAPD peritonitis.
Topics: Bacterial Infections; Candidiasis; Ceftazidime; Drug Therapy, Combination; Humans; Peritoneal Dialysis; Peritoneal Dialysis, Continuous Ambulatory; Peritonitis; Vancomycin | 1985 |
Intravenous vancomycin as initial treatment for gram-positive peritonitis in patients on chronic peritoneal dialysis.
Topics: Adult; Aged; Evaluation Studies as Topic; Humans; Injections, Intravenous; Middle Aged; Peritoneal Dialysis; Peritonitis; Staphylococcal Infections; Streptococcal Infections; Streptococcus pyogenes; Streptokinase; Vancomycin | 1985 |
[Pharmacokinetics of vancomycin in chronic renal failure patients in continuous ambulatory peritoneal dialysis (CAPD) after intra-abdominal administration].
Topics: Diffusion; Female; Half-Life; Humans; Kidney Failure, Chronic; Kinetics; Male; Middle Aged; Peritoneal Dialysis, Continuous Ambulatory; Peritoneum; Peritonitis; Staphylococcal Infections; Vancomycin | 1985 |
Vancomycin in the treatment of CAPD peritonitis.
Topics: Humans; Peritonitis; Vancomycin | 1985 |
Vancomycin and netilmicin as first line treatment of peritonitis in CAPD patients.
Topics: Adult; Bacteria; Drug Combinations; Drug Resistance, Microbial; Female; Gentamicins; Humans; Netilmicin; Peritoneal Dialysis; Peritoneal Dialysis, Continuous Ambulatory; Peritonitis; Vancomycin | 1985 |
Vancomycin and tobramycin in the treatment of CAPD peritonitis.
Topics: Adolescent; Adult; Aged; Bacterial Infections; Cefuroxime; Coagulase; Drug Resistance, Microbial; Exudates and Transudates; Female; Gram-Negative Bacteria; Humans; Male; Middle Aged; Peritoneal Dialysis, Continuous Ambulatory; Peritonitis; Staphylococcus; Streptococcus; Tobramycin; Vancomycin | 1985 |